Anthony Fauci

Q: What Schools Are Affiliated With Anthony Fauci

Anthony Fauci is affiliated with the following schools: College of the Holy Cross, Columbia University, Pennsylvania State University, University of Oxford, Weill Cornell Medicine, University of Pennsylvania, University of Genoa, Georgetown University, University of Minnesota

Why Is Anthony Fauci Influential?

According to Wikipedia, Anthony Stephen Fauci is an American physician-scientist and immunologist serving as the director of the National Institute of Allergy and Infectious Diseases and the Chief Medical Advisor to the President.

Anthony Fauci's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Papers

Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 (3659)
Wegener granulomatosis: an analysis of 158 patients. (2553)
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. (2060)
The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). (1870)
Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. (1853)
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. (1784)
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. (1775)
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. (1737)
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. (1647)
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth (1608)
The challenge of emerging and re-emerging infectious diseases (1532)
Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. (1523)
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease (1474)
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. (1442)
Coronavirus Infections-More Than Just the Common Cold. (1327)
Helicobacter pylori in peptic ulcer disease. (1297)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. (1284)
Covid-19 — Navigating the Uncharted (1102)
The immunopathogenesis of human immunodeficiency virus infection. (1072)
The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. (1071)
Zika Virus in the Americas--Yet Another Arbovirus Threat. (911)
Glucocorticosteroid therapy: mechanisms of action and clinical considerations. (886)
Host factors and the pathogenesis of HIV-induced disease (882)
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. (877)
Corticosteroid‐Mediated Immunoregulation in Man (855)
Multifactorial nature of human immunodeficiency virus disease: implications for therapy. (798)
Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. (793)
Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes (781)
The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. (768)
Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations (762)
HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. (739)
Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals (719)
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. (718)
WEGENER'S GRANULOMATOSIS: STUDIES IN EIGHTEEN PATIENTS AND A REVIEW OF THE LITERATURE (709)
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. (692)
Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. (690)
Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. (687)
Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV (659)
Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. (653)
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. (643)
B cells in HIV infection and disease (610)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. (593)
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease (586)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. (558)
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. (554)
The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. (554)
Takayasu Arteritis (539)
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. (531)
Ending the HIV Epidemic: A Plan for the United States. (516)
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. (507)
Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms (505)
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. (502)
Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis (499)
Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. (498)
Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV* (492)
Sjögren's syndrome (Sicca syndrome): current issues. (481)
CD25+CD4+ Regulatory T Cells from the Peripheral Blood of Asymptomatic HIV-infected Individuals Regulate CD4+ and CD8+ HIV-specific T Cell Immune Responses In Vitro and Are Associated with Favorable Clinical Markers of Disease Status (480)
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages (479)
Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. (477)
Lymphoid organs function as major reservoirs for human immunodeficiency virus. (474)
Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. (458)
Inherited Resistance to HIV-1 Conferred by an Inactivating Mutation in CC Chemokine Receptor 5: Studies in Populations with Contrasting Clinical Phenotypes, Defined Racial Background, and Quantified Risk (450)
The immunopathogenesis of HIV infection. (447)
Cyclophosphamide therapy of severe systemic necrotizing vasculitis. (444)
Toward an Understanding of the Correlates of Protective Immunity to HIV Infection (443)
Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. (433)
The Common γ-Chain Cytokines IL-2, IL-7, IL-15, and IL-21 Induce the Expression of Programmed Death-1 and Its Ligands (422)
The 1918 influenza pandemic: insights for the 21st century. (422)
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. (416)
Emerging Infectious Diseases: Threats to Human Health and Global Stability (409)
Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. (400)
Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy (400)
Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. (392)
Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy (391)
HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells (388)
The perpetual challenge of infectious diseases. (388)
Mechanisms of glucocorticoid action on immune processes. (387)
Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus (385)
Infection and replication of HIV-1 in purified progenitor cells of normal human bone marrow (382)
Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. (377)
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome. (373)
AIDS: Re-emergence of HIV after stopping therapy (371)
Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (370)
Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor (365)
Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. (358)
Immunopathogenic Mechanisms of HIV Infection (357)
Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines (356)
The persistent legacy of the 1918 influenza virus. (351)
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection (348)
Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. (347)
Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. (343)
Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. (342)
Infectious diseases: considerations for the 21st century. (339)
Surgical Pathology of the Lung in Wegener's Granulomatosis: Review of 87 Open Lung Biopsies From 67 Patients (336)
Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. (334)
New concepts in the immunopathogenesis of HIV infection. (328)
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection. (327)
Latent reservoirs of HIV: obstacles to the eradication of virus. (325)
Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. (324)
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. (323)
Takayasu's arteritis and its therapy. (318)
Immunoregulatory aberrations in systemic lupus erythematosus. (315)
Pathogenic mechanisms of HIV disease. (313)
Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. (312)
A strategic approach to COVID-19 vaccine R&D (312)
Interpretation of Head and Neck Biopsies in Wegener's Granulomatosis: A Pathologic Study of 126 Biopsies in 70 Patients (310)
Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS. (310)
Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. (310)
HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals (309)
Intestinal infections in patients with the acquired immunodeficiency syndrome (AIDS). Etiology and response to therapy. (308)
Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. (300)
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. (297)
Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption. (293)
Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA. (293)
Ophthalmic involvement in acquired immunodeficiency syndrome. (292)
Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. (289)
Global Vaccine Action Plan 2011-2020. (283)
Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. (280)
An HIV vaccine--evolving concepts. (280)
The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. (280)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis. (277)
Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection (275)
Increasing viral burden in CD4+ T cells from patients with human immunodeficiency virus (HIV) infection reflects rapidly progressive immunosuppression and clinical disease. (274)
The ocular manifestations of Wegener's granulomatosis. Fifteen years experience and review of the literature. (274)
Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. (272)
Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. (272)
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable. (271)
The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 (269)
Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. (268)
Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. (267)
HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. (266)
The AIDS epidemic--considerations for the 21st century. (265)
Monocyte function in the acquired immune deficiency syndrome. Defective chemotaxis. (264)
Universal voluntary testing and treatment for prevention of HIV transmission. (264)
Isolated angiitis of the central nervous system. Prospective diagnostic and therapeutic experience. (262)
Malignant lymphoma and erythrophagocytosis simulating malignant histiocytosis. (261)
Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro. (261)
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. (257)
Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects. (257)
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention (256)
A new immunodeficiency disorder in humans involving NK cells (253)
Therapy of the hypereosinophilic syndrome. (249)
Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. (248)
A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases (246)
Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. (244)
The Acquired Immunodeficiency Syndrome: An Update (243)
Structural characterization of reverse transcriptase and endonuclease polypeptides of the acquired immunodeficiency syndrome retrovirus (242)
Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infections. (242)
Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. (241)
HIV Vaccine Research: The Way Forward (241)
HIV and AIDS: 20 years of science (240)
The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection (238)
The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. (237)
The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis. (237)
The effect of cytokines and pharmacologic agents on chronic HIV infection. (236)
Effect of tumor necrosis factor alpha on mitogen-activated human B cells (233)
Wegener granulomatosis in children and adolescents: clinical presentation and outcome. (231)
Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. (231)
Host factors in the pathogenesis of HIV disease (228)
Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF Superfamily (228)
ANTI-RETROVIRAL EFFECTS OF INTERFERON-α IN AIDS-ASSOCIATED KAPOSI'S SARCOMA (225)
B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy. (223)
Both Memory and CD45RA+/CD62L+ Naive CD4+ T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (222)
Immunopathogenesis of the Acquired Immunodeficiency Syndrome (221)
The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. (221)
Expression of chemokine receptors CXCR4 and CCR5 in HIV-1-infected and uninfected individuals. (220)
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function (219)
HARRISON'S PRINCIPLES OF INTERNAL MEDICINE, 13TH EDITION: (216)
Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. (216)
Emerging infections: a perpetual challenge (215)
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. (215)
Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus (215)
Antimicrobial Resistance. (214)
Influenza vaccines for the future. (214)
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy (211)
B Cells of HIV-1–Infected Patients Bind Virions through Cd21–Complement Interactions and Transmit Infectious Virus to Activated T Cells (211)
Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases (211)
Race against time (210)
Emerging Pandemic Diseases: How We Got to COVID-19 (209)
AIDS--an immunologic reevaluation. (208)
Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection. (206)
What is a pandemic? (205)
Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. (203)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (201)
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. (199)
Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: Correlation with increased IL-7 (199)
CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction. (197)
Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. (195)
Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. (195)
Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis. (193)
Immunopathogenesis of HIV infection. (192)
Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. (192)
Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals (189)
Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. (188)
Serologic and immunologic studies in patients with AIDS in North America and Africa. The potential role of infectious agents as cofactors in human immunodeficiency virus infection. (187)
Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. (187)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells (187)
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. (185)
Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry. (182)
Ebola--underscoring the global disparities in health care resources. (181)
Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection (181)
Early antibody therapy can induce long-lasting immunity to SHIV (181)
EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO (181)
ERYTHEMA ELEVATUM DIUTINUM: SKIN AND SYSTEMIC MANIFESTATIONS, IMMUNOLOGIC STUDIES, AND SUCCESSFUL TREATMENT WITH DAPSONE (181)
The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes. (181)
Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses. (179)
Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. (178)
Role of Lymphoid Organs in the Pathogenesis of Human Immunodeficiency Virus (HIV) Infection (177)
Dengue and hemorrhagic fever: a potential threat to public health in the United States. (177)
Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals (176)
The effect of Hydrocortisone on the kinetics of normal human lymphocytes. (176)
NK cells in HIV infection: Paradigm for protection or targets for ambush (176)
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. (175)
Compromised B cell responses to influenza vaccination in HIV-infected individuals. (174)
Pulmonary involvement in the collagen vascular diseases. (174)
Detection of HIV-1 RNA in the lamina propria of patients with AIDS and gastrointestinal disease. (174)
CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals. (173)
Bioterrorism: A clear and present danger (172)
Suppression of human B lymphocyte function by cyclophosphamide. (172)
HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication (170)
Enhanced: The Need for a Global HIV Vaccine Enterprise (169)
Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy (169)
HIV reservoirs as obstacles and opportunities for an HIV cure (169)
Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. (169)
Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and responses to therapy in 25 patients. (168)
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. (168)
Thirty Years of HIV and AIDS: Future Challenges and Opportunities (167)
Activation of human B lymphocytes. I. Direct plaque-forming cell assay for the measurement of polyclonal activation and antigenic stimulation of human B lymphocytes (166)
Human lymphocyte antigens: production of a monoclonal antibody that defines functional thymus-derived lymphocyte subsets. (165)
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. (165)
Alteration of T-cell functions by infection with HTLV-I or HTLV-II. (165)
Human Cyclic Neutropenia: Clinical Review and Long-Term Follow-up of Patients (165)
Impairment of neutrophil bactericidal capacity in patients with AIDS. (164)
Factitious fever and self-induced infection: a report of 32 cases and review of the literature. (164)
Immune correlates of vaccine protection against HIV-1 acquisition (163)
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndrome. (163)
Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. (162)
Immunopathogenic mechanisms of HIV infection. (162)
Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage (158)
Bacteremia due to Mycobacterium avium-intracellulare in the acquired immunodeficiency syndrome. (158)
Building a tuberculosis-free world: The Lancet Commission on tuberculosis (157)
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine. (157)
Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study (156)
Direct activation of human resting T cells by IL 2: the role of an IL 2 receptor distinct from the Tac protein. (156)
Alternate-day prednisone therapy and human lymphocyte subpopulations. (156)
HIV reservoirs: pathogenesis and obstacles to viral eradication and cure (155)
Pandemic Influenza Threat and Preparedness (155)
Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. (154)
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals (154)
Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV. (154)
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. (153)
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. (152)
The management of subglottic stenosis in patients with wegener's granulomatosis (151)
Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. (150)
Dermatologic manifestations of the hypereosinophilic syndrome. (150)
Relationship between residual plasma viremia and the size of HIV proviral DNA reservoirs in infected individuals receiving effective antiretroviral therapy. (149)
Mechanisms of corticosteroid action on lymphocyte subpopulations. IV. Effects of in vitro hydrocortisone on naturally occuring and mitogen-induced suppressor cells in man. (149)
Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. (149)
Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome. (148)
Short-cycle structured intermittent treatment of chronic HIV infection with highly active antiretroviral therapy: Effects on virologic, immunologic, and toxicity parameters (148)
Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. (148)
cDNA cloning of the B cell membrane protein CD22: a mediator of B-B cell interactions (148)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine (148)
Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells (147)
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease. (146)
CD8+ T-cell-derived soluble factor(s), but not β-chemokines RANTES, MIP-1α, and MIP-1β, suppress HIV-1 replication in monocyte/macrophages (146)
Lymphotoxin is an important T cell-derived growth factor for human B cells. (146)
Production of monoclonal antibodies reacting with peripheral blood mononuclear cell surface differentiation antigens. (146)
HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. (146)
Development of effective vaccines against pandemic influenza. (146)
SARS-CoV-2 Variants of Concern in the United States-Challenges and Opportunities. (144)
CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro. (144)
Human B Cell Activation, Proliferation and Differentiation (143)
Activation of human B lymphocytes XVI. Cellular requirements, interactions, and immunoregulation of pokeweed mitogen-induced total-immunoglobulin producing plaque-forming cells in peripheral blood. (143)
Polyangiitis overlap syndrome. Classification and prospective clinical experience. (142)
Comparison of the Effector Cells in Human Spontaneous Cellular Cytotoxicity and Antibody‐Dependent Cellular Cytotoxicity: Differential Sensitivity of Effector Cells to in Vivo and in Vitro Corticosteroids (142)
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study (141)
Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy (141)
Cytokine modulation of HIV expression. (141)
Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV Infection (141)
NK cells in HIV infection: paradigm for protection or targets for ambush (140)
Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection. (140)
Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease. (138)
Cloning and analysis of the promoter region of CXCR4, a coreceptor for HIV-1 entry. (137)
Harrisons principles of internal medicine - 15th edition (136)
Proliferative responses of normal human B lymphocytes. Development of an assay system for human B cell growth factor (BCGF). (136)
HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines. (136)
The effects of interleukin 1 on human B cell activation and proliferation. (136)
HIV-1 envelope induces activation of caspase-3 and cleavage of focal adhesion kinase in primary human CD4(+) T cells. (135)
An HIV vaccine--challenges and prospects. (133)
Insights into B cells and HIV‐specific B‐cell responses in HIV‐infected individuals (133)
Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. (131)
Serologic and immunologic studies in patients with AIDS in North America and Africa (130)
Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population. (130)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE. (128)
The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission (125)
Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. (125)
The Pathway to a Universal Influenza Vaccine. (123)
A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes (123)
Kaposi's sarcoma causing pulmonary infiltrates and respiratory failure in the acquired immunodeficiency syndrome. (123)
Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR alpha beta + and TCR gamma delta + to human immunodeficiency virus infection: a mechanism for CD4+ (T4) lymphocyte depletion. (123)
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. (123)
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. (123)
Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. (122)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (122)
Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. (122)
Both a precursor and a mature population of dendritic cells can bind HIV. However, only the mature population that expresses CD80 can pass infection to unstimulated CD4+ T cells. (121)
Activation of human B lymphocytes. II. Cellular interactions in the PFC response of human tonsillar and peripheral blood B lymphocytes to polyclonal activation by pokeweed mitogen. (120)
B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. (120)
Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation. (119)
Immunoglobulin replacement therapy by slow subcutaneous infusion. (118)
Immunopathogenesis of HIV infection (118)
Transforming growth factor-beta suppresses human B lymphocyte Ig production by inhibiting synthesis and the switch from the membrane form to the secreted form of Ig mRNA. (118)
Targeting α4β7 integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (118)
Multidrug-resistant and extensively drug-resistant tuberculosis: the National Institute of Allergy and Infectious Diseases Research agenda and recommendations for priority research. (117)
Chemokines, cytokines and HIV: a complex network of interactions that influence HIV pathogenesis (117)
Attenuation of HIV-associated human B cell exhaustion by siRNA downregulation of inhibitory receptors. (116)
The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage. (116)
In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics, and cellular requirements (116)
CD8+ T lymphocytes of patients with AIDS maintain normal broad cytolytic function despite the loss of human immunodeficiency virus-specific cytotoxicity. (116)
Activation of human B lymphocytes. III. Concanavalin A-induced generation of suppressor cells of the plaque-forming cell response of normal human B lymphocytes. (115)
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. (115)
The efficiency of acute infection of CD4+ T cells is markedly enhanced in the setting of antigen-specific immune activation (115)
Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions. (113)
Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. (113)
Emerging and Re-Emerging Infectious Diseases: Influenza as a Prototype of the Host-Pathogen Balancing Act (113)
Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. (112)
Vitamin and trace Mineral Deficiency and Excess (112)
The association of syphilis with risk of human immunodeficiency virus infection in patients attending sexually transmitted disease clinics. (112)
Detailed Studies on Expression and Function of CD19 Surface Determinant by Using B43 Monoclonal Antibody and the Clinical Potential of Anti-CD19 Immunotoxins (110)
The in vitro regulation of human thyrocyte HLA-DR antigen expression. (109)
Cyclophosphamide-induced remissions in advanced polyarteritis nodosa. (109)
HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV (108)
Human B lymphoma cell line producing B cell growth factor. (108)
Angiocentric immunoproliferative lesions: a clinicopathologic spectrum of post-thymic T-cell proliferations. (107)
The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses (107)
Human immunodeficiency virus (HIV) infection in CD4+ T lymphocytes genetically deficient in LFA-1: LFA-1 is required for HIV-mediated cell fusion but not for viral transmission (107)
Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. (106)
Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals (106)
Deleterious Effect of HIV-1 Plasma Viremia on B Cell Costimulatory Function (105)
Yellow Fever - Once Again on the Radar Screen in the Americas. (104)
The syndrome of Kaposi's sarcoma and opportunistic infections: an epidemiologically restricted disorder of immunoregulation. (104)
Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium-Mycobacterium intracellulare bacteremia in patients with AIDS. (103)
Mechanisms of the immunosuppressive and anti-inflammatory effects of glucocorticosteroids. (103)
Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis. (103)
A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-kappa B subunit p65 in vitro and may impair human immunodeficiency virus replication in these cells (102)
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States (102)
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. (102)
SARS-CoV-2 Viral Variants-Tackling a Moving Target. (102)
The next influenza pandemic: can it be predicted? (102)
Chediak-Higashi gene in humans. II. The selectivity of the defect in natural- killer and antibody-dependent cell-mediated cytotoxicity function (101)
Induction of phosphorylation and intracellular association of CC chemokine receptor 5 and focal adhesion kinase in primary human CD4+ T cells by macrophage-tropic HIV envelope. (101)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (101)
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parameters. (101)
Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome. (101)
Chikungunya at the door--déjà vu all over again? (100)
Selection of HIV-specific immunogenic epitopes by screening random peptide libraries with HIV-1-positive sera. (100)
Frequent detection of HIV-1-specific mRNAs in infected individuals suggests ongoing active viral expression in all stages of disease. (100)
Induction of expression of HIV in latently or chronically infected cells. (100)
Activation of human B lymphocytes. IV. Regulatory effects of corticosteroids on the triggering signal in the plaque-forming cell response of human peripheral blood B lymphocytes to polyclonal activation. (100)
Differential expression of cell activation markers after stimulation of resting human B lymphocytes. (100)
Successful treatment of sudden hearing loss in Cogan's syndrome with corticosteroids. (99)
Emerging and Reemerging Infectious Diseases: The Perpetual Challenge (99)
A potential role for adrenocorticotropin in regulating human B lymphocyte functions. (99)
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. (98)
Abnormal B cell memory subsets dominate HIV-specific responses in infected individuals. (98)
Emerging Viral Diseases: Confronting Threats with New Technologies (98)
Exposure to bacterial products renders macrophages highly susceptible to T-tropic HIV-1. (97)
A histamine-releasing factor from activated human mononuclear cells. (97)
Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals (96)
Further studies of the role of transforming growth factor-beta in human B cell function. (96)
Cutaneous pathology in Wegener's granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. (96)
High incidence of free monoclonal lambda light chains in the sera of patients with Sjogren's syndrome. (96)
Chronic granulomatous disease of childhood and Chromobacterium violaceum infections in the southeastern United States. (95)
Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1 (95)
Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy. (95)
B‐cell responses to HIV infection (94)
Experience with surgical treatment of Takayasu's disease. (94)
Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. (93)
Endothelins belong to the assortment of mast cell-derived and mast cell-bound cytokines. (93)
Immunomodulators in Clinical Medicine (93)
Effects of in vivo prednisone on in vitro eosinophil and neutrophil adherence and chemotaxis. (93)
HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. (93)
Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products. (93)
Impact of HIV on Cell Survival and Antiviral Activity of Plasmacytoid Dendritic Cells (92)
Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. (92)
Selective suppression of an early step in human B cell activation by cyclosporin A (91)
Development of a human T-T cell hybridoma secreting B cell growth factor. (91)
Effect of Immune Activation on the Dynamics of Human Immunodeficiency Virus Replication and on the Distribution of Viral Quasispecies (91)
Immunopathogenesis of the acquired immunodeficiency syndrome. (90)
Death in the AIDS patient: role of cytomegalovirus. (90)
Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy. (90)
Lymphokine-induced phagocytosis in angiocentric immunoproliferative lesions (AIL) and malignant lymphoma arising in AIL. (89)
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations (89)
Human bone marrow lymphocytes. I. Distribution of lymphocyte subpopulations in the bone marrow of normal individuals. (89)
Developmental therapeutics and the acquired immunodeficiency syndrome. (89)
IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. (88)
Measles in 2019 - Going Backward. (88)
Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism. (87)
Polyclonal activation of bone-marrow-derived lymphocytes from human peripheral blood measured by a direct plaque-forming cell assay. (87)
Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. (87)
Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters. (87)
IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage. (87)
Comprar Harrison's Principles of Internal Medicine. 18th Ed. 2 Volúmenes | Dennis Kasper | 9780071748896 | Mcgraw-Hill Education (86)
Interferons in the pathogenesis and treatment of human immunodeficiency virus infection. (86)
Induction of expression of human immunodeficiency virus in a chronically infected promonocytic cell line by ultraviolet irradiation. (86)
A simple method for the determination of complement receptor-bearing mononuclear cells. (86)
T cell enrichment and depletion of human peripheral blood mononuclear cell preparations. Unexpected findings in the study of the functional activities of the separated populations. (86)
CD4+ T-lymphocytopenia without HIV infection--no lights, no camera, just facts. (85)
Alternate-day corticosteroid therapy. (85)
Cross-linking of CD30 induces HIV expression in chronically infected T cells. (85)
Cloning and analysis of the promoter region of CCR5, a coreceptor for HIV-1 entry. (85)
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication (85)
Mechanisms of human cell-mediated cytotoxicity. I. Modulation of natural killer cell activity by cyclic nucleotides. (84)
The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. (84)
Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells. (84)
Ear disease in patients with wegener's granulomatosis (83)
Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells. (82)
Ending AIDS--is an HIV vaccine necessary? (82)
Pilot study of the effects of intermittent interleukin-2 on human immunodeficiency virus (HIV)-specific immune responses in patients treated during recently acquired HIV infection. (82)
A randomized controlled safety/efficacy trial of therapeutic vaccination in HIV-infected individuals who initiated antiretroviral therapy early in infection (81)
Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression. (80)
Unusual radiographic features of Wegener's granulomatosis. (80)
Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. (80)
USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. (80)
Seasonal and pandemic influenza preparedness: science and countermeasures. (80)
Factors Secreted by Human T Lymphotropic Virus Type I (HTLV-I)–infected Cells Can Enhance or Inhibit Replication of HIV-1 in HTLV-I–uninfected Cells: Implications for In Vivo Coinfection with HTLV-I and HIV-1 (80)
Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma. (79)
Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. (79)
Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. (79)
Mechanisms of antibody-dependent cellular cytotoxicity: the use of effector cells from chronic granulomatous disease patients as investigative probes. (79)
Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. (78)
Monoclonal Antibodies for Emerging Infectious Diseases - Borrowing from History. (78)
Expression of chemokine and inhibitory receptors on natural killer cells: effect of immune activation and HIV viremia. (78)
Role of complement in host defense against experimental disseminated candidiasis. (78)
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor (77)
Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides. (77)
Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV. (76)
Pathogenesis of vasculitis syndromes. (76)
Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes (76)
A Way Forward: The National HIV/AIDS Strategy and Reducing HIV Incidence in the United States (76)
Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. (76)
The perpetual challenge of antimicrobial resistance. (76)
Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms (76)
Smallpox vaccination policy--the need for dialogue. (76)
Toward an AIDS-free generation. (76)
Cutaneous Pathology in Wegener's Granulomatosis (76)
Innate Immune Dysfunction in HIV Infection: Effect of HIV Envelope-NK Cell Interactions12 (76)
Immunoregulation in autoimmunity. (75)
The role of lymphoid organs in the pathogenesis of HIV infection. (75)
Two‐dimensional Echocardiographic Assessment of the Idiopathic Hypereosinophilic Syndrome: Anatomic Basis of Mitral Regurgitation and Peripheral Embolization (75)
Renal biopsy pathology in Wegener's granulomatosis. (75)
HIV-1 gp120 impairs B cell proliferation by inducing TGF-β1 production and FcRL4 expression (75)
Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse (74)
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor (74)
Emerging Infectious Diseases in 2012: 20 Years after the Institute of Medicine Report (74)
Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies. (74)
Paucity of HIV DNA Methylation in Latently Infected, Resting CD4+ T Cells from Infected Individuals Receiving Antiretroviral Therapy (74)
Antigen-induced in vitro antibody production in humans: a model for B cell activation and immunoregulation. (74)
Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions. (73)
Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells (72)
Immunoregulation in infection caused by Mycobacterium tuberculosis: the presence of suppressor monocytes and the alteration of subpopulations of T lymphocytes. (72)
IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. (72)
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes (72)
Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. (72)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease. (71)
Antigen-specific human T-cell clones: development of clones requiring HLA-DR-compatible presenting cells for stimulation in presence of antigen. (71)
Therapy for Early COVID-19: A Critical Need. (71)
Letter: Pulmonary aspergillosis, inhalation of contaminated marijuana smoke, chronic granulomatous disease. (71)
Dengue research opportunities in the Americas. (71)
Efficacy of ascorbic acid in Chediak-Higashi syndrome (CHS): studies in humans and mice. (71)
Apoptosis in HIV infection (70)
Ending the HIV-AIDS Pandemic--Follow the Science. (70)
Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle (70)
Radiation therapy of midline granuloma. (69)
Transmission of multidrug-resistant human immunodeficiency virus--the wake-up call. (68)
Immune Activation with HIV Vaccines (68)
Multifactorial nature of noncytolytic CD8+ T cell-mediated suppression of HIV replication: beta-chemokine-dependent and -independent effects. (68)
HIV-1 Vaccines and Adaptive Trial Designs (68)
B-cell exhaustion in HIV infection: the role of immune activation (67)
Decreased nucleotide and serotonin storage associated with defective function in Chediak-Higashi syndrome cattle and human platelets. (67)
Intradermal influenza vaccination--can less be more? (67)
Asthma in the inner city: the perspective of the National Institute of Allergy and Infectious Diseases. (67)
Current therapy in allergy, immunology, and rheumatology (66)
Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons. (66)
R5 and X4 HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells. (66)
Combination chemotherapy of disseminated Kaposi's sarcoma in patients with the acquired immune deficiency syndrome. (66)
Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals. (66)
Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. (65)
CD40-Mediated Induction of CD4 and CXCR4 on B Lymphocytes Correlates with Restricted Susceptibility to Human Immunodeficiency Virus Type 1 Infection: Potential Role of B Lymphocytes as a Viral Reservoir (65)
The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammator (65)
Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir (65)
Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. (64)
Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. (64)
Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig. (64)
Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T-lymphocytic cells (64)
CXCR4 and CCR5 Genetic Polymorphisms in Long-Term Nonprogressive Human Immunodeficiency Virus Infection: Lack of Association with Mutations other than CCR5-Δ32 (64)
Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual (64)
Ending the HIV/AIDS Pandemic (63)
Tumor necrosis factor a induces expression of human immunodeficiency virus in a chronically infected T-cell clone (63)
Tickborne Diseases - Confronting a Growing Threat. (63)
Defective HIV-1 proviruses produce viral proteins (63)
Differential effect of monoclonal anti-DR antibody on monocytes in antigen- and mitogen-stimulated responses: mechanism of inhibition and relationship to interleukin 1 secretion. (63)
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases. (62)
The challenge of emerging and re-emerging infectious diseases (62)
Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms. (61)
The relationship between antibody affinity and the efficiency of complement fixation. (61)
Induction of nuclear factor-kappa B and the human immunodeficiency virus long terminal repeat by okadaic acid, a specific inhibitor of phosphatases 1 and 2A. (61)
Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells. (60)
Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens. (60)
Abnormalities of immunoregulatory T cell subsets in patients with insulin-dependent diabetes mellitus. (59)
25 years of HIV (59)
An improved technique for the negative selection of large numbers of human lymphocytes and monocytes by counterflow centrifugation--elutriation. (59)
Human B Cell Function in a Polyclonally Induced Plaque Forming Cell System. Cell Triggering and Immunoregulation (58)
Considerations for Developing a Zika Virus Vaccine. (58)
The need for a global HIV vaccine enterprise. Policy forum. (58)
B cell growth factor and T cell growth factor produced by mitogen-stimulated normal human peripheral blood T lymphocytes are distinct molecules. (58)
Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations. (58)
Association between Takayasu's arteritis and a B-cell alloantigen in North Americans. (58)
Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding. (57)
Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. (57)
Deficiency of active natural killer cells in the Chediak-Higashi syndrome. Localization of the defect using a single cell cytotoxicity assay. (57)
The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. (57)
Idiopathic midline destructive disease (IMDD): a subgroup of patients with the "midline granuloma" syndrome. (56)
Immunohistochemical characterization of intrathyroid lymphocytes in Graves' disease. Interstitial and intraepithelial populations. (56)
H7N9 Avian Influenza A Virus and the Perpetual Challenge of Potential Human Pandemicity (56)
Association of Wegener's granulomatosis with HLA-B8. (56)
Immunological reactivity of the lung. I. A guinea pig model for the study of pulmonary mononuclear cell subpopulations. (56)
Bioterrorism on the home front: a new challenge for American medicine. (56)
The research agenda of the National Institute of Allergy and Infectious Diseases for antimicrobial resistance. (56)
Pandemic influenza viruses--hoping for the road not taken. (55)
An HIV Vaccine Is Essential for Ending the HIV/AIDS Pandemic. (55)
Complement subcomponent C1q stimulates Ig production by human B lymphocytes. (55)
Heterozygosity for a defective gene for CC chemokine receptor 5 is not the sole determinant for the immunologic and virologic phenotype of HIV-infected long-term nonprogressors. (55)
Direct effects of a monoclonal B cell differentiation factor and of purified interleukin 1 on B cell differentiation. (55)
Biochemical and Biological Characterization of a Dodecameric CD4-Ig Fusion Protein (55)
Human Blood Monocytes: Characterization of Negatively Selected Human Monocytes and Their Suspension Cell Culture Derivatives (55)
Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection (55)
A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection. (55)
Productive HIV infection of resting CD4+ T cells: role of lymphoid tissue microenvironment and effect of immunomodulating agents. (55)
In vivo T lymphocyte origin of macrophage-tropic strains of HIV. Role of monocytes during in vitro isolation and in vivo infection. (55)
Characterization of Plasmablasts in the Blood of HIV-Infected Viremic Individuals: Evidence for Nonspecific Immune Activation (55)
Activation of human B lymphocytes. X. Heterogeneity of concanavalin A-generated suppressor cells of the pokeweed mitogen-induced plaque-forming cell response of human peripheral blood lymphocytes. (54)
Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle. (54)
Cyclophosphamide suppression of established cell-mediated immunity. Quantitative vs. qualitative changes in lymphocyte populations. (54)
The Bb fragment of complement factor B acts as a B cell growth factor (54)
Selective infection of human CD4+ cells by simian immunodeficiency virus: productive infection associated with envelope glycoprotein-induced fusion. (54)
Mechanisms of corticosteroid action on lymphocyte subpopulations. VI. Lack of correlation between glucocorticosteroid receptors and the differential effects of glucocorticosteroids on T-cell subpopulations. (54)
Effect of antiretroviral therapy on HIV reservoirs in elite controllers. (54)
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. (54)
NIH conference. Acquired immunodeficiency syndrome: epidemiologic, clinical, immunologic, and therapeutic considerations. (54)
Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells of immunized subjects. (54)
Antigen-induced in vitro antibody production in humans: tetanus toxoid-specific antibody synthesis. (54)
CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. (54)
Efficacy of intermittent colchicine therapy in familial Mediterranean fever. (54)
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals (54)
Twenty-Five Years of HIV/AIDS (53)
Production of B cell growth factor by normal human B cells. (53)
Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome. (53)
Genetic Characterization of Rebounding Human Immunodeficiency Virus Type 1 in Plasma during Multiple Interruptions of Highly Active Antiretroviral Therapy (53)
Adjuvant effect of cholera enterotoxin on the immune response of the mouse to sheep red blood cells. (52)
The effect of Hydrocortisone on the kinetics of normal human lymphocytes. (52)
Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 (51)
Pandemic influenza's 500th anniversary. (51)
Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? (51)
Oligoclonal immunoglobulins in patients with the acquired immunodeficiency syndrome. (51)
New and reemerging diseases: the importance of biomedical research. (51)
Inhibition of polyclonal B-cell activation by suppressor monocytes in patients with sarcoidosis. (51)
Comorbidities in Persons With HIV: The Lingering Challenge. (51)
HIV Envelope Induces Virus Expression from Resting CD4+ T Cells Isolated from HIV-Infected Individuals in the Absence of Markers of Cellular Activation or Apoptosis1 (51)
Immunologic reactivity of the lung. III. Effects of corticosteroids on alveolar macrophage cytotoxic effector cell function. (50)
Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation. (50)
Direct effect of interleukin 2 on the differentiation of human B cells which have not been preactivated in vitro (50)
Identification of multiple and distinct CD8+ T cell suppressor activities: dichotomy between infected and uninfected individuals, evolution with progression of disease, and sensitivity to gamma irradiation. (50)
MALIGNANCIES IN THE AIDS PATIENT: NATURAL HISTORY, TREATMENT STRATEGIES, AND PRELIMINARY RESULTS (50)
Activation of human B lymphocytes. VIII. Differential radiosensitivity of subpopulations of lymphoid cells involved in the polyclonally-induced PFC responses of peripheral blood B lymphocytes. (49)
Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. (49)
Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis. (49)
Mechanisms of corticosteroid action on lymphocyte subpopulations. III. Differential effects of dexamethasone administration on subpopulations of effector cells mediating cellular cytotoxicity in man. (49)
Peripheral neuropathy in hypereosinophilic syndrome (49)
Resistance to HIV–1 infection: It's in the genes (49)
Promonocytic U937 subclones expressing CD4 and CXCR4 are resistant to infection with and cell-to-cell fusion by T-cell-tropic human immunodeficiency virus type 1 (49)
Correction of human cyclic neutropenia with prednisolone. (49)
Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. (49)
HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells. (48)
Immunologic abnormalities in the acquired immunodeficiency syndrome. (48)
Use of interleukin-2 in patients with acquired immunodeficiency syndrome. (48)
Activation and regulation of human immune responses: implications in normal and disease states. (48)
HIV vaccine development--improving on natural immunity. (48)
Transforming Growth Factor‐β Is a Potent Negative Regulator of Human Lymphocytes (48)
CD40 Ligand Trimer and IL-12 Enhance Peripheral Blood Mononuclear Cells and CD4+ T Cell Proliferation and Production of IFN-γ in Response to p24 Antigen in HIV-Infected Individuals: Potential Contribution of Anergy to HIV-Specific Unresponsiveness (47)
Pathogenesis of HIV and SIV (47)
Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV. (47)
Wegener's granulomatosis and related diseases. (47)
Mutational analysis of the p50 subunit of NF-kappa B and inhibition of NF-kappa B activity by trans-dominant p50 mutants (47)
Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells (47)
gp120 is present on the plasma membrane of apoptotic CD4 cells prepared from lymph nodes of HIV‐1‐infected individuals: an immunoelectron microscopic study (47)
Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. (47)
Relationship between alternate-day corticosteroid therapy and behavioral abnormalities. (47)
Immunopathogenesis of HIV Infection (46)
Human B cell activation and cell cycle progression: stimulation with anti‐μ and Staphylococcus aureus Cowan strain I (46)
Ocular findings in patients with neutrophil dysfunction. (46)
The T cell receptor Vβ repertoire in HIV-1 infection and disease (46)
Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. (46)
Eosinophil kinetics in the hypereosinophilic syndrome. (45)
Demonstration that human B cells respond differently to interleukin 2 and B cell differentiation factor based on their stages of maturation. (45)
Interleukin-2 and human immunodeficiency virus infection: Pathogenic mechanisms and potential for immunologic enhancement (45)
Novel vaccine technologies for the 21st century (45)
High-dose immunoglobulin replacement therapy by slow subcutaneous infusion during pregnancy. (45)
Infectious disease testing for blood transfusions. NIH Consensus Development Panel on Infectious Disease Testing for Blood Transfusions. (44)
Selective pressure exerted by immunodominant HIV‐1‐specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope (44)
CpG Oligonucleotides Enhance Proliferative and Effector Responses of B Cells in HIV-Infected Individuals1 (44)
The 2009 H1N1 Pandemic Influenza Virus: What Next? (44)
Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection (44)
Diabetes insipidus associated with Wegener's granulomatosis successfully treated with cyclophosphamide. (44)
Current issues in developing a strategy for dealing with the acquired immunodeficiency syndrome. (44)
Immunologic reactivity in the hypereosinophilic syndrome. (44)
Accumulation of human immunodeficiency virus‐specific cytotoxic T lymphocytes away from the predominant site of virus replication during primary infection (43)
Human Immunodeficiency Virus Type 1 Bound to B Cells: Relationship to Virus Replicating in CD4+ T Cells and Circulating in Plasma (43)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes. (43)
Disseminated candidiasis. i. an experimental model in the guinea pig. (43)
Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. (43)
Cathepsin G, a Neutrophil-Derived Serine Protease, Increases Susceptibility of Macrophages to Acute Human Immunodeficiency Virus Type 1 Infection (43)
Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. (43)
Prospects for an HIV vaccine: leading B cells down the right path (43)
Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda. (42)
Cell-mediated immune responses in humans after induced infection with influenza A virus. (42)
Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. (42)
A platelet abnormality in the Chediak-Higashi syndrome of man. (42)
Benefits and Risks of Influenza Research: Lessons Learned (41)
Neonatal natural killer cells produce chemokines and suppress HIV replication in vitro. (41)
Polyarteritis nodosa, hairy cell leukemia and splenosis. (41)
Opioids and Infectious Diseases: A Converging Public Health Crisis. (41)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (41)
The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system. (41)
Cyclosporin A modulation of early virologic and immunologic events during primary simian immunodeficiency virus infection in rhesus monkeys. (41)
The role of lymphoid organs in the immunopathogenesis of HIV infection (41)
Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation (41)
A Paradoxical Treatment for a Paradoxical Condition: Infliximab Use in Three Cases of Mycobacterial IRIS. (40)
Ethics of clinical research in the developing world (40)
HIV-AIDS: much accomplished, much to do (40)
The role of the CD4 receptor versus HIV coreceptors in envelope-mediated apoptosis in peripheral blood mononuclear cells. (40)
Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy. (40)
Ending the global HIV/AIDS pandemic: the critical role of an HIV vaccine. (40)
4F2 monoclonal antibody recognizes a surface antigen on spread human fibroblasts of embryonic but not of adult origin (40)
Characterization of lymphocytes in bronchial lavage fluid from monkeys. (40)
The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener's granulomatosis. (40)
Innate Immunity in HIV Infection: Enhanced Susceptibility to CD95-Mediated Natural Killer Cell Death and Turnover Induced by HIV Viremia (40)
NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. (39)
Recurrence of Wegener's granulomatosis after kidney transplantation. Successful re-induction of remission with cyclophosphamide. (39)
Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up. (39)
Activation and immunoregulation of antigen-specific human b lymphocyte responses: multifaceted role of the monocyte. (39)
Intercellular adhesion molecules (ICAM)‐1 ICAM‐2 and ICAM‐3 function as counter‐receptors for lymphocyte function‐associated molecule 1 in human immunodeficiency virus‐mediated syncytia formation (39)
In vitro reactivation of human immunodeficiency virus 1 from latently infected, resting CD4+ T cells after bacterial stimulation. (39)
Experimental disseminated candidiasis. II. Administration of glucocorticosteroids, susceptibility to infection, and immunity. (39)
Recombinant interleukin 2 and gamma-interferon act synergistically on distinct steps of in vitro terminal human B cell maturation. (38)
Immunopathogenesis of human immunodeficiency virus infection. (38)
Mechanisms of corticosteroid action on lymphocyte subpopulations. V. Effects of in vivo hydrocortisone on the circulatory kinetics and function of naturally occuring and mitogen-induced suppressor cells in man. (38)
Clonal analysis of T lymphocytes in the acquired immunodeficiency syndrome. Evidence for an abnormality affecting individual helper and suppressor T cells. (38)
Immunopathogenic Mechanisms in Human Immunodeficiency Virus (HIV) Infections (37)
Pathogenesis of HIV disease: opportunities for new prevention interventions. (37)
Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing (37)
Wegener's granulomatosis (37)
Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis. (37)
Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. (37)
Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. (36)
Pathogenic insights from studies of lymphoid tissue from HIV-infected individuals. (36)
Harrison's Infectious Diseases (36)
Response: The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis (36)
Recombinant interleukin-2-induced polyclonal proliferation of in vitro unstimulated human peripheral blood lymphocytes. (35)
Sequential synergistic effect of interleukin 2 and interferon-gamma on the differentiation of a Tac-antigen-positive B cell line. (35)
Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. (35)
Activated human T cells can present denatured antigen. (35)
Immunologic reconstitution in the acquired immunodeficiency syndrome. (35)
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn (35)
Chronic, recurrent small-vessel cutaneous vasculitis. Clinical experience in 13 patients. (35)
Activation of human B lymphocytes. XI. Differential effects of azathioprine on B lymphocytes and lymphocyte subpopulations regulating B cell function. (35)
Astrocyte-conditioned medium stimulates HIV-1 expression in a chronically infected promonocyte clone (34)
Defective plasmacytoid dendritic cell-NK cell cross-talk in HIV infection. (34)
Role for CD21 in the Establishment of an Extracellular HIV Reservoir in Lymphoid Tissues1 (34)
Neuropsychiatric aspects of AIDS. (34)
Necrotizing vasculitis, coronary angiitis, and the cardiologist. (34)
Pulmonary Involvement in the Collagen Vascular Diseases1,2 (34)
Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. (33)
Successful renal transplantation in Wegener's granulomatosis. (33)
Unusual etiologies of fever and their evaluation. (33)
Autologous and allogeneic intercellular interactions: modulation by adherent cells, irradiation, and in vitro and in vivo corticosteroids. (33)
Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression (33)
Activation of human B lymphocytes. V. Kinetics and mechanisms of suppression of plaque-forming cell responses by concanavalin A-generated suppressor cells. (33)
Four Decades of HIV/AIDS - Much Accomplished, Much to Do. (33)
Eastern Equine Encephalitis Virus - Another Emergent Arbovirus in the United States. (33)
A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda (33)
Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. (33)
Preventing the Spread of SARS-CoV-2 With Masks and Other "Low-tech" Interventions. (33)
The Idiopathic Hypereosinophilic Syndrome (32)
Tracking HIV during disease progression. (32)
Alteration of T-lymphocyte subpopulations in sarcoidosis. (32)
Effect of anti‐V3 antibodies on cell‐free and cell‐to‐cell human immunodeficiency virus transmission (32)
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells. (32)
Conducting clinical trials in outbreak settings: Points to consider (32)
Immunologic characterization of a helper T-cell lymphoma. (32)
HIV‐1 infection in the lymphoid organs (32)
Influenza Vaccines: Good, but We Can Do Better. (31)
Controlling and ultimately ending the HIV/AIDS pandemic: a feasible goal. (31)
Immunoglobulin G antineutrophil cytoplasmic antibodies are produced in the respiratory tract of patients with Wegener's granulomatosis. (31)
Erysipelothrix rhusiopathiae bacteremia presenting as septic shock. (31)
Isolation and Quantitation of HIV in Peripheral Blood (31)
Selective activation of antigen-specific human B cells in recently immunized individuals by nonspecific factors in the absence of antigen. (31)
Humans with chronic granulomatous disease maintain humoral immunologic memory despite low frequencies of circulating memory B cells. (31)
Immunosuppressive and anti-inflammatory effects of glucocorticoids. (30)
Divergent effects of cyclophosphamide administration on mononuclear killer cells: quantitative depletion of cell numbers versus qualitative suppression of functional capabilities. (30)
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 (30)
Human T cell leukemia/lymphoma virus-infected antigen-specific T cell clones: indiscriminant helper function and lymphokine production. (30)
CT of the paranasal sinuses and orbits in patients with Wegener's granulomatosis. (30)
Maturational characteristics of HIV-specific antibodies in viremic individuals. (30)
The Ba fragment of complement factor B inhibits human B lymphocyte proliferation. (30)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation (30)
Dissociation between syncytia formation and HIV spreading. Suppression of syncytia formation does not necessarily reflect inhibition of HIV infection (30)
Cytokine regulation of acute and chronic HIV infection in vitro: from cell lines to primary mononuclear cells. (30)
Early Treatment of SIV+ macaques with an α4β7 mAb alters virus distribution and preserves CD4+ T cells in later stages of infection (30)
Development and Evaluation of a Vaccine for Human Immunodeficiency Virus (HIV) Infection (30)
Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. (30)
What Recent History Has Taught Us About Responding to Emerging Infectious Disease Threats (30)
Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process. (30)
Treatment with IL-7 Prevents the Decline of Circulating CD4+ T Cells during the Acute Phase of SIV Infection in Rhesus Macaques (29)
AIDS--an immunologic reevaluation. (29)
Selective abrogation of antigen-specific human B cell responses by antigen-ricin conjugates (29)
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts (29)
Evaluation of lymph node virus burden in human immunodeficiency virus-infected patients receiving efavirenz-based protease inhibitor--sparing highly active antiretroviral therapy. (29)
Research in the Context of a Pandemic (29)
Toward an HIV vaccine: A scientific journey (29)
Activation of human B lymphocytes (28)
Characterization of thymus-derived lymphocyte subsets in acute Epstein-Barr virus-induced infectious mononucleosis. (28)
Granulomatous vasculitides: distinct but related. (28)
Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1. (28)
Human astrocytes stimulate HIV-1 expression in a chronically infected promonocyte clone via interleukin-6. (28)
An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals (28)
HYDROCORTISONE, PREDNISONE, ENDOTOXIN, AND ETIOCHOLANOLONE (27)
Paranasal sinus obliteration in Wegener granulomatosis. (27)
Differential effects of interleukin 2 vs B cell growth factor on human B cells. (27)
Activated human T cells can present alloantigens but cannot present soluble antigens. (27)
The Role of Integrin α4β7 in HIV Pathogenesis and Treatment (27)
A Framework for Decisions About Research with HPAI H5N1 Viruses (27)
Anopheles gambiae Genome: Completing the Malaria Triad (27)
Lymphomatoid granulomatosis and angiocentric lymphoma: A spectrum of post-thymic T-cell proliferations (27)
Human lymphocyte surface markers. (27)
Immunologic Abnormalities in the Acquired Immunodeficiency Syndrome (27)
Lymphokine Production by B Cells from Normal and HIV‐Infected Individuals (27)
Differentiation of Promonocytic U937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor(s) Which Modulates Fusion/Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (27)
25 Years of HIV/AIDS Science: Reaching the Poor with Research Advances (27)
Relationship of the genes for Chediak-Higashi syndrome (beige) and the T-cell receptor gamma chain in mouse and man. (26)
Activation of human B lymphocytes (26)
The story behind COVID-19 vaccines (26)
Immunolgic reactivity of the lung. V. Regulatory effects of antibody on the pulmonary immune response to locally administered antigen. (26)
Development of suppressor T lymphocytes for Epstein-Barr virus-induced B-lymphocyte outgrowth during acute infectious mononucleosis: assessment by two quantitative systems. (26)
Interaction of pokeweed mitogen with monocytes in the activation of human lymphocytes. (26)
PEPFAR - 15 Years and Counting the Lives Saved. (26)
An HIV cure: feasibility, discovery, and implementation. (26)
Wegener's Granulomatosis (26)
The direct effects of interleukin 1, interleukin 2, Interferon-α, Interferon-γ, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells (25)
Filarial parasite-specific T cell lines: induction of IgE synthesis. (25)
Activation of human B lymphocytes. XIII. Characterization of multiple populations of naturally occurring immunoregulatory cells of polyclonally induced in vitro human B cell function. (25)
B-cell growth factor receptor expression and B-cell growth factor response of leukemic B cell precursors and B lineage lymphoid progenitor cells. (25)
Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120 (25)
Nef, macrophages and B cells: a highway for evasion (25)
HIV/AIDS in 1998--gaining the upper hand? (25)
Nonspecific interstitial pneumonitis in patients with AIDS: radiologic features. (25)
Enhancing effects of adjuvanted 2009 pandemic H1N1 influenza A vaccine on memory B-cell responses in HIV-infected individuals (25)
Biodefence on the research agenda (24)
Harrison's rheumatology (24)
Kaposi's Sarcoma of the Head and Neck in the Acquired Immune Deficiency Syndrome (24)
Mechanisms of Lymphocyte Activation and Immune Regulation (24)
CORTICOSTEROIDS IN HUMAN LYMPHOCYTE‐MEDIATED CYTOTOXIC REACTIONS: EFFECTS ON THE KINETICS OF SENSITIZATION AND ON THE CYTOLYTIC CAPACITY OF EFFECTOR LYMPHOCYTES IN VITRO (24)
Immunologic abnormalities in the acquired immunodeficiency syndrome (AIDS). (24)
Human bone marrow lymphocytes. Cytotoxic effector cells in the bone marrow of normal individuals. (24)
Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma. (24)
The expanding global health agenda: a welcome development (24)
Neoplasm and systemic vasculitis: a case report. (24)
Encyclopedia of pestilence, pandemics, and plagues (24)
Immunological reactivity of the lung: VII. Effect of corticosteroids and cyclophosphamide on the Fc receptor function of alveolar macrophages (24)
Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies (24)
The immune adherence receptor: dissociation between the expression of erythrocyte and mononuclear cell C3b receptors. (23)
In vitro antigen-induced antibody responses to hepatitis B surface antigen in man. Kinetic and cellular requirements. (23)
Antiretroviral monotherapy in early stage human immunodeficiency virus disease has no detectable effect on virus load in peripheral blood and lymph nodes. (23)
Activation of human B lymphocytes. IX. Modulation of antibody production by products of activated macrophages. (23)
Comparative analysis of constitutive cytokine expression in peripheral blood and lymph nodes of HIV-infected individuals. (23)
The global challenge of infectious diseases: the evolving role of the National Institutes of Health in basic and clinical research (23)
The complex challenges of HIV vaccine development require renewed and expanded global commitment (23)
Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor. (23)
Induction of HIV-1 replication by allogeneic stimulation. (23)
HTLV type I Tax activation of the CXCR4 promoter by association with nuclear respiratory factor 1. (23)
Biomedical research--an integral component of national security. (23)
Increased expression of HLA-DR antigens in hydrocortisone-treated monocytes. (22)
Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. (22)
Visual and auditory anomalies in Chediak-Higashi syndrome. (22)
Familial vasculitis: report of 2 families. (22)
Human trials of AIDS vaccines: current status and future directions (22)
Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function. (22)
Cytokine regulation of HIV expression. (22)
The Critical Role of Biomedical Research in Pandemic Preparedness. (22)
Immunoblastic sarcoma of the central nervous system in a patient with lymphomatoid granulomatosis (22)
Serum angiotensin-converting enzyme and lysozyme in granulomatous diseases of unknown cause. (22)
Concomitant pulmonary aspergillosis and nocardiosis in a patient with chronic granulomatous disease of childhood. (22)
The clinical use of glucocorticoids. (22)
Analysis of the expression of the 4F2 surface antigen in normal and neoplastic fibroblastic human cells of embryonic and adult origin. (22)
NIAID workshop on immunity to malaria: addressing immunological challenges (21)
Emerging infectious diseases: a clear and present danger to humanity. (21)
Basic science: Bedrock of progress. (21)
Virologic and immunologic events in primary HIV infection (21)
Characterization of a T4+/Leu-8+ T cell clone that directly helps B cell Ig production by secreting B cell differentiation factor. (21)
Diagnostic and therapeutic aspects of the surgical approach to Wegener's granulomatosis. (21)
Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens. (21)
Herpes zoster in patients with treated Wegener's granulomatosis. A possible role for cyclophosphamide. (21)
Elevated levels of tumor necrosis factor-alpha in Zairian neonate plasmas: implications for perinatal infection with the human immunodeficiency virus. (21)
Host defense against Mycobacterium-avium complex. (21)
Subpopulations of human T lymphocytes. (21)
Immunological reactivity of the lung. IV. Effect of cyclophosphamide on alveolar macrophage cytotoxic effector function. (21)
AIDS: Let Science Inform Policy (21)
Lymphocyte-mediated cytotoxicity against human allogeneic and autologous lymphoid targets after concanavalin A-activation of cytotoxic effector cells. (21)
Improvement of antibody functionality by structure-guided paratope engraftment (21)
The modulation of membrane Ia on human B lymphocytes. (21)
The AIDS research model: implications for other infectious diseases of global health importance. (20)
Immunology research: challenges and opportunities in a time of budgetary constraint (20)
Less common manifestations and presentations of Wegener's granulomatosis. (20)
Investing to meet the scientific challenges of HIV/AIDS. (20)
Transmission of drug-resistant strains of HIV-1: unfortunate, but inevitable (20)
Characterization of the direct effects of cyclophosphamide on cell-mediated immunological responses. (20)
Computer Assisted Tomography of Orbital Lesions in Wegener's Granulomatosis (20)
Optimal immunity to HIV--natural infection, vaccination, or both? (20)
Immunopathology and pathogenesis of human immunodeficiency virus infection. (20)
Human B lymphocyte function: cell triggering and immunoregulation. (20)
Cardiovascular effects and safety of intravenous and intramuscular pentamidine isethionate. (20)
Immunopathogenic Mechanisms of HIV Infection (20)
Dramatic remissions in severe systemic necrotizing vasculitis (SNV) with cyclophosphamide (CY) therapy (20)
Emerging Pandemic Diseases: How We Got to COVID-19 (19)
Acute Flaccid Myelitis: Something Old and Something New (19)
Identification of a receptor for high molecular weight human B cell growth factor. (19)
Lymphocyte populations in acute viral gastroenteritis (19)
An HIV Vaccine: Mapping Uncharted Territory. (19)
Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection (19)
Mechanisms of human cell-mediated cytotoxicity. II. Correction of the selective defect in natural killing in the Chediak-Higashi syndrome with inducers of intracellular cyclic GMP. (19)
Classification and Prospective Clinical Experience (19)
HIV cure research: a formidable challenge (18)
Further studies of natural killer cell function in Chediak-Higashi patients. (18)
The hypereosinophilic syndrome: dramatic response to therapeutic intervention. (18)
Thoracic manifestations of the acquired immune deficiency syndrome. (18)
MAdCAM costimulation through Integrin-α4β7 promotes HIV replication (18)
Short Communication HTLV Type I Tax Activation of the CXCR4 Promoter by Association with Nuclear Respiratory Factor 1 (18)
Harrisons Manual of Medicine (18)
Opioid Injection in Rural Areas of the United States: A Potential Obstacle to Ending the HIV Epidemic. (18)
Activation of human B lymphocytes VII. the regulatory effect of cyclic adenosine monophosphate on human B cell activation. (18)
Host-based antipoxvirus therapeutic strategies: turning the tables. (18)
GATA-1 transcription factor transactivates the promoter for CCR5, a coreceptor for human immunodeficiency virus type 1 entry. (17)
Cell-Mediated Cytotoxicity in Recurrent Herpes Simplex Virus Infections in Man (17)
MSM, AIDS research activism, and HAART (17)
Leukotriene C4 produced by a human T-T hybridoma suppresses Ig production by human lymphocytes. (17)
Emerging and Reemerging Infectious Diseases: The Dichotomy Between Acute Outbreaks and Chronic Endemicity (17)
Human bone marrow lymphocytes. III. Polyclonal activation of B lymphocytes in human bone marrow measured by a direct plaque-forming cell assay. (17)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7 (17)
Pandemic Zika: A Formidable Challenge to Medicine and Public Health (17)
Refocusing Research on Sexually Transmitted Infections. (16)
Human B-lymphocyte function : activation and immunoregulation (16)
Heterogeneity of acute lymphocytic leukemia cell surface markers as detected by monoclonal antibodies. (16)
Hypereosinophilic syndrome human eosinophil degranulation induced by soluble and particulate stimuli (16)
Diagnostic and therapeutic approach to the patient with vasculitis. (16)
HIV-1 gp120: A Target for Therapeutics and Vaccine Design. (16)
Trapped but still dangerous (16)
Identification and characterization of a B cell activation factor (BCAF) produced by a human T cell line. (16)
The Role of US Government Agencies in Vaccine Research And Development (16)
Analysis of Fcγ receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, Tγ cells and cells labeled with the 3A1 anti‐T cell monoclonal antibody (16)
The world must build on three decades of scientific advances to enable a new generation to live free of HIV/AIDS. (16)
Immune responses of human lymphocytes in vitro. (15)
Apparent direct cellular cytotoxicity mediated via cytophilic antibody. Multiple Fc receptor bearing effector cell populations mediating cytophilic antibody induced cytotoxicity. (15)
Species-Specific Differences in the Expression and Regulation of α4β7 Integrin in Various Nonhuman Primates (15)
Comprar Harrison's Principles of Internal Medicine, Self-Assessment and Board Review | Joseph Loscalzo | 9780071496193 | Mcgraw-Hill Education (15)
Diffuse histiocytic lymphoma in a patient treated with cyclophosphamide for Wegener's granulomatosis. (14)
A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS) (14)
Harrison's principles of internal medicine : companion handbook (14)
Pulmonary vasculitis. (14)
AIDS in 1996. Much accomplished, much to do. (14)
The vasculitides. (14)
Suppression of antibody synthesis. I. Evidence for a circulating inhibitor of antibody synthesis demonstrable at the cellular level. (14)
Detection and characterization of human high molecular weight B cell growth factor receptors on leukemic B cells in chronic lymphocytic leukemia. (14)
Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit (14)
Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation. (14)
Facial erysipelas in the immunocompromised host. Report of two cases. (13)
IMMUNOLOGICAL FEATURES OF WEGENER'S GRANULOMATOSIS (13)
Host factors in the pathogenesis of HIV disease. (13)
Short Communication: The Role of Dendritic Cells in the Infection of CD4+ T Cells with the Human Immunodeficiency Virus: Use of Dendritic Cells from Individuals Homozygous for the Δ32CCR5 Allele as a Model (13)
The Chronically Infected Promonocytic Cell Line U1: A Model of HIV Expression Regulated by Cytokines (13)
Activation, proliferation, and differentiation of circulating B cells in autoimmune thyroid disease. (13)
An Historical Antecedent of Modern Guidelines for Community Pandemic Influenza Mitigation (13)
Classics in medicine (13)
Buerger's disease in a young woman. (13)
Peripheral blood myeloid progenitor cell cultures in patients with hypereosinophilic syndrome (CFU-eos in hypereosinophilic syndrome). (13)
Development and characterization of interleukin-2-independent antigen-specific human T cell clones that produce multiple lymphokines. (13)
Current therapy in allergy and immunology 1983-1984 (13)
NIH Response to Open Letter (13)
Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward (13)
Lymphocyte depletion and immunosuppression with repeated leukapheresis by continuous flow centrifugation. (13)
Transforming growth factor-beta is a potent negative regulator of human lymphocytes. (13)
AIDS–challenges to basic and clinical biomedical research (13)
Bone Marrow Plasma Cells Are a Primary Source of Serum HIV-1–Specific Antibodies in Chronically Infected Individuals (12)
Wegener's granulomatosis: studies in eighteen patients and a review of the literature. 1973. (12)
Differential sensitivity of human lymphocyte subpopulations to azathioprine. (12)
Therapeutic approaches to patients with AIDS. (12)
CXCR4/IgG-expressing plasma cells are associated with human gastrointestinal tissue inflammation. (12)
Immunology of aids: Approaches to understanding the immunopathogenesis of HIV infection (12)
Activation of human B lymphocytes. XV. Spontaneously occurring and mitogen-induced indirect anti-sheep red blood cell plaque-forming cells in normal human peripheral blood. (12)
The effect of cyclosporine on immunization with tetanus and keyhole limpet hemocyanin (KLH) in humans (12)
Host factors that affect sexual transmission of HIV. (12)
Dendritic cells express and use multiple HIV coreceptors. (12)
Corticosteroids in autoimmune disease. (12)
Progress in drug therapies for HIV infection. (12)
Reimagining the Research Approach to Tuberculosis† (11)
STIMULATION OF PHAGOCYTOSIS BY A T CELL LYMPHOMA-DERIVED LYMPHOKINE (11)
Corticosteroid-induced modulation of immunoglobulin secretion by human B lymphocytes: potentiation of background mitogenic signals. (11)
Nocardia astéroïdes sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. (11)
Cytokine Cascades in HIV Infection (11)
Erratum: Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates (Proceedings of the National Academy of Sciences of the United States of America (December 9, 2003) 100, 25 (15011-15016)) (11)
Early idiopathic hemochromatosis with absent stainable bone marrow iron stores (11)
The Chediak-Higashi gene in humans. III. Studies on the mechanisms of NK impairment. (11)
Immunological reactivity of the lung II. Cytotoxic effector function of pulmonary mononuclear cell subpopulations. (11)
Stages in the progression of HIV infection in chimpanzees. (11)
Human Immunodeficiency Virus/AIDS in the Era of Coronavirus Disease 2019: A Juxtaposition of 2 Pandemics (11)
Harrison's Gastroenterology and Hepatology (11)
Radiation therapy of midline granuloma (11)
Smallpox immunization in the 21st century: the old and the new. (11)
Reaching everyone, everywhere with life-saving vaccines (11)
Early treatment of SIV plus macaques with an alpha(4)beta(7) mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection (11)
Regulation of human B-cell activation, proliferation, and differentiation by soluble factors (11)
Human Immunodeficiency Virus Type 1 (HIV-1) Non-B Subtypes Are Similar to HIV-1 Subtype B in that Coreceptor Specificity Is a Determinant of Cytopathicity in Human Lymphoid Tissue Infected Ex Vivo (11)
Diadenosine 5',5'''-p1,p4-tetraphosphate deficiency in blood platelets of the Chédiak-Higashi syndrome. (11)
Development of a human T-T cell hybridoma secreting B cell growth factor (11)
Suppression of antibody synthesis. II. The effect of carrier-specific cellsupon haptenic competition. (10)
Nocardia asteroides sinusitis. Presentation as a trimethoprim-sulfamethoxazole responsive fever of unknown origin. (10)
Quantitative and qualitative effects of cyclophosphamide administration on circulating polymorphonuclear leucocytes. (10)
Combination therapy for HIV infection: getting closer. (10)
Interferon‐γ induces light chain synthesis in interleukin 2 stimulated human B cells (10)
About this journal. (10)
The acquired immune deficiency syndrome. The ever-broadening clinical spectrum. (10)
Retreatment of HCV Genotype-1 with Sofosbuvir and Ledipasvir after Relapse with Sofosbuvir and Ribavirin: A Pilot Study (10)
Durable Control of HIV Infection in the Absence of Antiretroviral Therapy: Opportunities and Obstacles. (10)
Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques (10)
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation (10)
Benchmarks for antiretroviral therapy. (10)
Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome. (10)
Vasculitis: new insights amid old enigmas. (10)
Chromobactehum violaceum Infectious and Chronic Granulomatous Disease (10)
AIDS: immunopathogenic mechanisms and research strategies. (10)
Focusing to achieve a world without AIDS. (10)
Human T4+ lymphocytes produce a phagocytosis-inducing factor (PIF) distinct from interferon-alpha and interferon-gamma. (10)
Different requirements for Ia-bearing accessory cells in mitogen versus antigen induction of human B-cell responses. (9)
Lithium carbonate for recurrent fever and neutropenia. (9)
The T cell receptor V beta repertoire in HIV-1 infection and disease. (9)
Evolution in the structure and distribution of 4F2‐antigen from the oncofetal to the adult phenotype of human fibroblasts (9)
Antibody-dependent cellular cytotoxicity mediated by subpopulations of human T lymphocytes: killing of human erythrocytes and autologous lymphoid cells. (9)
Immunologic aspects of the acquired immunodeficiency syndrome (9)
The human autologous mixed lymphocyte reaction. II. Analysis of activation and proliferation. (9)
The Extended Impact of Human Immunodeficiency Virus/AIDS Research (9)
Host defense againstMycobacterium-avium complex (9)
Salmonella Susceptibility (9)
Bioterrorism: defining a research agenda. (9)
Acquired immunodeficiency syndrome may present as severe restrictive lung disease. (9)
Antigen-induced human T cell help. Precursor frequency, radiation sensitivity, and allogeneic effects. (9)
Both Memory and CD 45 RA 1 / CD 62 L 1 Naive CD 4 1 T Cells Are Infected in Human Immunodeficiency Virus Type 1-Infected Individuals (8)
A visual assay to monitor purification of cell surface antigens reacting with monoclonal antibodies. (8)
NIH conference. The acquired immunodeficiency syndrome: an update. (8)
IMMUNOPATHOGENESIS OF HIV INFECTION 1 (8)
COVID-19: The therapeutic landscape (8)
Current strategies in the treatment of HIV infection. (8)
Evidence for susceptibility of intrathymic T cell precursors to human immunodeficiency virus infection: a mechanism for T4 (CD4) lymphocyte depletion. (8)
Continuous flow leukapheresis induces expression of stress genes in lymphocytes: impact on microarray analyses. (8)
The search for an HIV vaccine, the journey continues (8)
The activation, proliferation, and differentiation of human B lymphocytes. (8)
The Role of the Virtuous Investigator in Protecting Human Research Subjects (8)
Antiretroviral therapy and immunologic reconstitution in AIDS. (8)
Modulation of human B cell responses by a monoclonal antibody to an activation antigen 4F2. (8)
Current Concepts Influenza Vaccines for the Future (8)
Human B-cell proliferation in response to recombinant interleukin 2 is not due to T-cell help. (8)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (8)
Gamma (immune) interferon production by leukocytes from a patient with a TG cell proliferative disease (8)
The relationship between immunization and circulating antigen-specific plaque-forming cells. (8)
Lack of generation of killer cells in the mixed lymphocyte reaction between mitogen-stimulated and unstimulated autologous lymphocytes. (8)
Kinetics of plasma HIV rebound in the era of modern antiretroviral therapy. (8)
B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor (8)
The effects of corticosteroids on immunoregulation in sarcoidosis. (8)
Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. (8)
In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome. (8)
Achieving an AIDS-free world: science and implementation (8)
Idiopathic midline granuloma. (7)
WEGENER GRANULOMATOSIS. REPLY (7)
Suppression of the generation of human con A-induced cytotoxic effector cells by con A-activated suppressor cells. (7)
Activated cytotoxic lymphocytes in lymph nodes from human immunodeficiency virus (HIV) 1‐infected patients: a light and electronmicroscopic study (7)
Antiviral immunity in HIV-1 infected long-term non-progressors (LTNPs) (7)
200 Leukotriene B4, C4 and D4 generation by human eosinophils (7)
Preface: Evolving Ethical Issues Over the Course of the AIDS Pandemic (7)
A Centenary Tale of Two Pandemics: The 1918 Influenza Pandemic and COVID-19, Part I. (7)
Dengue: The Continual Re-Emergence of a Centuries-Old Disease (7)
Immunologic Reconstitution in the Acquired Immunodeficiency Syndrome (7)
Synergy of helper factors in the differentiation of in vivo-preactivated antigen-specific human B cells. (7)
An elusive soluble suppressor (7)
ddI--a good start, but still phase I. (7)
Correlation with increased IL-7 (7)
The revolution in clinical immunology. (7)
Comprar Harrison's Infectious Diseases | Anthony S. Fauci | 9780071702935 | Mcgraw-Hill Education (7)
Ending the HIV Pandemic: Optimizing the Prevention and Treatment Toolkits. (7)
Achieving an AIDS-free World: Science and Implementation (7)
Human immunodeficiency virus. Trapped but still dangerous. (6)
Comprar Harrison's Manual of Medicine | Dennis Kasper | 9780071477437 | Mcgraw-Hill Education (6)
Universal Coronavirus Vaccines - An Urgent Need. (6)
Association Between Human Immunodeficiency Virus Infection and Cardiovascular Diseases: Finding a Solution to Double Jeopardy. (6)
Current Studies Examining Regulation of the Human B Cell Cycle (6)
Chromobacterium violaceum infectious and chronic granulomatous disease. (6)
The pathology of idiopathic midline destructive disease (IMDD) in the eyelid. (6)
Histopathology of ocular changes in chronic granulomatous disease. (6)
Pillars Article: production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986. 163: 1037-1050. (6)
The development of an AIDS vaccine: progress and promise. (6)
123 – The Immunology of Human Immunodeficiency Virus Infection (6)
Treatment of immune complex-mediated diseases: Corticosteroids and cytotoxic agents (6)
Antigen-specific human B-cell responses: modulation by immunoregulatory T-cell subsets. (6)
MAdCAM costimulation through Integrin-alpha(4)beta(7) promotes HIV replication (6)
Viral persistence in HIV infection: much known, much to learn. (6)
The V2 loop of HIV gp120 delivers costimulatory signals to CD4+ T cells through Integrin α4β7 and promotes cellular activation and infection. (6)
Purification of human monocyte-macrophages by a cell suspension culture technique. (6)
Activation of human B lymphocytes. XIV. Characterization of the precursor of the pokeweed mitogen-induced anti-sheep red blood cell plaque-forming cell. (6)
15. Differential effects of in vivo hydrocortisone on human T cell subpopulations (6)
Wegener's granulomatosis and other systemic granulomatous conditions. (6)
lmmunoregulation in autoimmunity (6)
Human immunodeficiency virus disease : AIDS and related disease (6)
Comprar Harrison's Manual Of Medicine 19th Ed. | D. Kasper | 9780071828529 | MCGRAW HILL (5)
Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to alpha4beta7 (5)
Harrison's Infectious Diseases, 2/E (5)
Peripheral Neuropathy in Chediak-Higashi Syndrome (5)
Monocyte t cell interactions in the immuno regulation of human b cell reactivity (5)
Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals. (5)
CHAPTER 2 – POKEWEED MITOGEN-INDUCED PFC RESPONSES OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES: REGULATION OF B-CELL TRIGGERING (5)
The Acquired Immune Deficiency Syndrome: The Ever-Broadening Clinical Spectrum. (5)
Advances in host defense mechanisms. Volume 1. Phagocytic cells. (5)
Meeting the Challenge of Epidemic Chikungunya. (5)
NIH conference. Immunomodulators in clinical medicine. (5)
Overview of clinical syndromes and immunology of AIDS. (5)
Ending the HIV Epidemic in the United States: Closing the Implementation Gaps (5)
Corticosteroids and circulating lymphocytes. (5)
Decade of Vaccines. Foreword. (5)
2005 Robert H. Ebert Memorial Lecture Emerging and Re-emerging Infectious Diseases: The Perpetual Challenge (5)
Impact of Treatment Interruption on HIV Reservoirs and Lymphocyte Subsets in Individuals Who Initiated Antiretroviral Therapy During the Early Phase of Infection. (5)
Demonstration of major histocompatibility complex restriction in man using an antigen-specific proliferating T cell clone. (4)
Prevention of HIV Transmission Universal Voluntary Testing and Treatment for (4)
Transforming biomedical research to develop effective TB vaccines: the next ten years. (4)
In Memoriam: Robert M. Chanock, MD, 1924–2010. (4)
Immunopathogenic mechanisms of human immunodeficiency virus disease: implications for therapy. (4)
Chromobacterium violaceum infections and chronic granulomatous disease. (4)
Immunogenic Properties of Human Gamma Globulin Free of Endotoxin Contamination (4)
A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques. (4)
Therapeutic approach to the vasculitic syndromes. (4)
HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics. (4)
Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level. (4)
Diadenosine 5',5'''-p1,p4-tetraphosphate deficiency in blood platelets of the Chédiak-Higashi syndrome. (4)
Early treatment of HIV-1 infection (4)
Comprar Harrison Manual de Medicina Interna 18ed | Dan Longo | 9786071509505 | Mcgraw-Hill Interamericana (4)
Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis-pancytopenia syndrome. (4)
Infection by HIV Chemokine Receptor 5 Expression and Cells : CXC Chemokine Receptor 4 and CC Progenitor + Peripheral Blood-Derived CD 34 (4)
Catalysing HIV/TB research: a meeting report (4)
Addressing the Tuberculosis Epidemic: 21st Century Research for an Ancient Disease (4)
Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus (4)
11 The aids epidemic: Demographic aspects, population biology, and virus evolution (4)
The effects of interleukin-1, interleukin-2, alpha-interferon, and gamma-interferon on human B lymphocytes. (4)
Idiopathic CD 4 + T Lymphocytopenia is Associated with Increases in Immature / Transitional B Cells and Serum Levels of IL-7 Short title : ICL linked to abnormal B cells and elevated IL-7 (4)
Translating Research into Therapies (4)
Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection (4)
Glucocorticoid effects on circulating human mononuclear cells. (4)
The role of dendritic cells in the infection of CD4+ T cells with the human immunodeficiency virus: use of dendritic cells from individuals homozygous for the delta32CCR5 allele as a model. (3)
Leukemic B-cell precursors constitutively express functional receptors for human interleukin-1. (3)
Immunoregulation in autoimmunity. (3)
B-cell abnormalities in AIDS. (3)
T cell homeostasis in HIV infection: part of the solution, or part of the problem? (3)
The Forgotten Forefather: Joseph James Kinyoun and the Founding of the National Institutes of Health (3)
Emerging and Re-Emerging Infectious Diseases: The Perpetual Challenge to Global Health (3)
Functional and biochemical characterization of B-cell differentiation factor (BCDF) produced by an HTLV-I-transformed human T-cell clone and demonstration of specific binding of the factor to a BCDF responsive cell line. (3)
Successful management of hepatic abscesses by percutaneous catheter drainage in chronic granulomatous disease. (3)
Biochemical and Biological Characterization of a Dodecameric CD 4-Ig Fusion Protein IMPLICATIONS FOR THERAPEUTIC AND VACCINE (3)
AIDS: newer concepts in the immunopathogenic mechanisms of human immunodeficiency virus disease. (3)
CYTOLYTIC T LYMPHOCYTES IN MIXED LYMPHOCYTE CULTURE (3)
The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. (3)
Impact of Biomedical Research on the AIDS Epidemic (3)
2019: A Banner Year for Tuberculosis Research. (3)
The effect of in vivo hydrocortisone (OHC) on in vitro lymphocyte function in humans (3)
The vasculitic syndromes. (3)
Biochemical characterization of human B-cell growth factor (BCGF)☆☆☆ (3)
Audio Interview: A Covid-19 Conversation with Anthony Fauci. (3)
Head and neck manifestations of histiocytic medullary reticulosis (3)
Human cyclic neutropenia (3)
Activation of human B lymphocytes. XVII. Synergy between nonspecific and specific signals in the antigen-specific responses of human B cells. (3)
Role of T-cell trafficking in the pathogenesis of HIV disease (3)
A Universal Flu Vaccine Is Vital. (3)
Letter: Midline granuloma or Wegener's granulomatosis. (3)
Cytotoxic cellular immunity and cytomegalovirus lessons from studies of the acquired immunodeficiency syndrome and immunosuppressed allograft recipients (3)
Immunologic aspects of cardiovascular disease. (3)
The National Institute of Allergy and Infectious Diseases' asthma research programs: a retrospective. (3)
Chronic granulomatous disease. Diagnosis in a 27-year-old man with Mycobacterium fortuitum. (3)
Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man. (3)
Thoracic mass lesions in immuno-incompetent patients. (3)
Analysis of Fc gamma receptors on human peripheral blood leukocytes by flow microfluorometry. I. Receptor distributions on monocytes, T gamma cells and cells labeled with the 3Al anti-T cell monoclonal antibody. (3)
Regulation of Human B Cell Growth (2)
Pathogenic Mechanisms of HIV Disease: The Role of Viral Replication and Immune Activation (2)
Fighting infectious disease threats via research: a talk with Anthony S. Fauci. (2)
Heparin and lymphocyte kinetics: use in studies on the mechanisms of corticosteroid-induced peripheral lymphocytopenia. (2)
Dichotomy between antigen and mitogen induced t cell help in human b cell activation (2)
Update on and Future Directions for Use of Anti–SARS-CoV-2 Antibodies: National Institutes of Health Summit on Treatment and Prevention of COVID-19 (2)
CHAPTER 19 – EFFECT OF HYDROCORTISONE ON THE KINETICS AND FUNCTION OF PERIPHERAL BLOOD IMMUNOREGULATORY CELLS IN MAN (2)
Production of phagocytosis-inducing factor and expression of 4B4 antigen by cloned human T cells before and after transformation with HTLV-I. (2)
Immunologic characterization of a helper T-cell lymphoma. (2)
US puts flu vaccines on trial. Interview by Declan Butler. (2)
Early treatment of HIV-1 infection (multiple letters) [3] (2)
Defining and Defeating the Intolerable Burden of Malaria III. Progress and Perspectives (2)
Characterization of concanavalin a generated suppressor cells of the plaque forming cell response of human peripheral blood lymphocytes (2)
Infectious complications complications of cyclophosphamide treatment for vasculitis (2)
Persistently elevated abnormal B‐cell subpopulations and anti‐core antibodies in patients co‐infected with HIV/HCV who relapse (2)
Gamma (immune) interferon produced by leukocytes from a patients with a T cell proliferation disease. (2)
Letter: Monocytopenia after prednisone. (2)
The scientific agenda for AIDS. (2)
Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage. (2)
From mRNA sensing to vaccines (2)
Production of monoclonal antibody recognizing a subpopulation of human B lymphocytes producing B cell growth factor (BCGF) (2)
N-acetyl-cysteine is a potent suppressor of human immunodeficiency virus transcription in persistently infected cells. (2)
HIV envelopes induce distinct gene expression profiles in primary peripheral blood mononuclear cells (2)
The Spectrum of Vasculitis (2)
Authorsʼ reply to correspondence by Le and Farrar (2)
[The nephrotic syndrome in congenital syphilis]. (2)
The Jules Bordet Lecture. Immunopathogenesis of HIV infection. (2)
Anthony S. Fauci, MD, Director, National Institute of Allergy and Infectious Diseases (2)
KL01 Ending the HIV/AIDS Pandemic: From Scientific Advances to Public Health Implementation (2)
Interferon-gamma induces light chain synthesis in interleukin 2 stimulated human B cells. (2)
International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK (2)
7 – Immunopathologic Mechanisms of Human Immunodeficiency Virus (HIV) Infection (2)
Dengue vaccine clinical trials in India - An opportunity to inform the global response to a re-emerging disease challenge. (2)
The direct effects of interleukin 1, interleukin 2, interferon-alpha, interferon-gamma, B-cell growth factor, and a B-cell differentiation factor on resting and activated human B cells. (2)
Cytokines and Immunoregulatory Factors in the Pathogenesis of HIV Infection: TNF Effects (2)
Clinical Effects of Immunosuppressive Agents: Targets and Mechanisms (2)
Research sheds light on treatment interruption. (2)
NIH conference. Development and evaluation of a vaccine for human immunodeficiency virus (HIV) infection. (2)
Immunity to Influenza: Catching a Moving Target To Improve Vaccine Design (2)
Response to: "Rescuing the NIH before it is too late". (2)
NIH research: Think globally (2)
A platelet abnormality in the Chediak-Higashi syndrome of man (2)
Differentiation of Promonocytic U 937 Subclones into Macrophagelike Phenotypes Regulates a Cellular Factor ( s ) Which Modulates Fusion / Entry of Macrophagetropic Human Immunodeficiency Virus Type 1 (2)
Biomedical research in an era of unlimited aspirations and limited resources. (1)
Alternative cytokines in the immunoregulation of the human B cell cycle. (1)
Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy. (1)
Wegener granulomatosis [3] (1)
Reversal with IL-10 Unbalanced Th 1-Type T Cell Cytokine Pattern : T Cells Exhibiting an + CD 4 + with HLA-DR Active Wegener ' s Granulomatosis Is Associated (1)
Human T4+ lymphocytes produce a phagocytosis-inducing factor distinct from α- and γ-interferon (1)
Reply to Brundage and Shanks (1)
Comprar Harrison's Rheumatology | Carol Langford | 9780071741439 | Mcgraw-Hill Education (1)
Host Factors in the Immunopathogenesis of HIV Disease (1)
Battling Ebola: the virus and the fear. (1)
Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa (1)
Victories against AIDS have lessons for COVID-19. (1)
Pharmacologic regulation of HIV expression. (1)
Immunologic Reactivity of the Lung (1)
Reports on nevirapine threaten public health (1)
Track A Basic Science (1)
37 – Human T Cell Clones Reactive with Soluble Antigens: Methodology, Specificity, and MHC Restriction (1)
Harrison's 14 CD-ROM (1)
Regulation of Human B Cell Function (1)
Letter: Immunological features of Wegener's granulomatosis. (1)
Antigenic competition at the cellular level: response of rabbit lymph node cells to the trinitrophenyl and p-arsanilic hapTENS. (1)
Temporal Aspects Of Hiv Dna And Rna Synthesis And Tissue Distribution During Hiv Infection (1)
Activation and immunoregulation of human B lymphocytes. (1)
Emerging concepts in the management of vasculitic diseases. (1)
Plaque-forming cell assays for human B cells (1)
P-C19 The in vivo effects of Anti-a4b7 in rhesus macaques during acute and chronic infection (1)
Efficient macrophage isolation of human immunodeficiency virus from peripheral blood leukocytes from healthy seropositive individuals: implications for cell tropism. (1)
Nonspecific Interstitial Pneumonitis in Patients with (1)
H-106 Sustained ART-free HIV remission: Obstacles and opportunities (1)
Characterization of an early thymocyte cell line which is chronically infected with the human immunodeficiency virus. (1)
Communications Antigenic Competition at the Cellular Level: Response of Rabbit Lymph Node Cells to the Trinitrophenyl and P-Arsanilie Haptens (1)
EFFECT OF VIRUS INFECTION ON POLYMORPHONUCLEAR LEUCOCYTES (1)
117 Ending the HIV/AIDS Pandemic: A Realistic Goal (1)
IMMUNOREGULATION OF HUMAN B LYMPHOCYTE FUNCTION BY PRODUCTS OF HYBRIDIZED AND CLONED T CELLS (1)
Effect of alternate day prednisone therapy on human lymphocyte subpopulations (1)
OBJECTIVE PROGNOSTIC FACTORS FOR PATIENTS WITH PNEUMOCYSTIS CARINII PNEUMONIA AND THE ACQUIRED IMMUNODEFICIENCY SYNDROME (1)
CCR5 Signal Transduction in Macrophages by Human Immunodeficiency Virus and Simian Immunodeficiency Virus Envelopes (1)
An HIV vaccine: breaking the paradigms. (1)
Inhibition of polyclonal B cell activation by hydrocortisone (HC)-sensitive suppressor monocytes in sarcoidosis (1)
Fitting a vaccine into the HIV prevention landscape (1)
Harrison's Online Updates (1)
MAdCAM signaling through integrin α4β7 modulates surface expression of CCR5 and markers of CD4+ T cell activation. (1)
C105 Glycosylation in HIV Transmission (1)
P07-01. The gut mucosal homing receptor integrin α4β7 forms a complex with CD4 and defines a T cell subset that is highly susceptible to infection by HIV-1 (1)
103 HIV-1 gp120 Interactions With the Gut Homing Receptor Integrin α4β7 on CD4+ T Cells (1)
New Science Aimed at an Ancient Killer (1)
MULTIPLE SUBPOPULATIONS OF LYMPHOID CELLS REGULATING HUMAN B CELL FUNCTION (1)
Chapter 257. Tumours of the large and small intestine (1)
Response: HIV Quasispecies and Resampling. (1)
Antibody production in man : in vitro synthesis and clinical implications : proceedings of the Catharijne Conference on Immunology held in Utrecht, Holland on March 15-18, 1978 (1)
A new series on the revolution in immunology. (1)
Role of CD8+ T Lymphocytes in the Pathogenesis of HIV Infection (1)
The ASCI, the spring meetings, and growing up in academic medicine: a personal perspective. (1)
Reply to kilbourne. (1)
HIV prevention research: progress and challenges in the new millennium (1)
A view from Washington through the eyes of an AAP physician-scientist: 2007 Association of American Physicians George M. Kober Medal. (1)
Infection of CD4+ Primary Cell Lines and Induction of HIV (1)
Investing To Meet The Scientific Challenges Of (1)
Individuals and CCR 5 in HIV-1-Infected and Uninfected Expression of Chemokine Receptors CXCR 4 (1)
Surgical aspects of systemic necrotizing vasculitis. (1)
Relationship between expression of Fcγ receptors or la antigens and cytolytic activities of alloactivated human T cells (1)
Strategies for Preventing HIV Transmission—Reply (1)
A living history of AIDS vaccine research. (1)
CHAPTER 23 – ABERRANT REGULATION OF B-CELL FUNCTION IN IMMUNOLOGICALLY MEDIATED DISEASES: SYSTEMIC LUPUS ERYTHEMATOSUS AND SARCOIDOSIS (1)
Evidence for CC-Chemokine-Dependent and to Replicate and Transmit HIV Infection : Stimulation on the Ability of Dendritic Cells Differential Effects of CD 40 Ligand / Trimer (0)
Cytokine-induced Cell Death And Expression Of Hiv-1. Do Tumor Necrosis Factor-α (tnf-α) And Interferon-γ (ifn-γ) Selectively Kill Hiv-infected Cells? (0)
Correction (0)
Induction of polyclonal B cell activation and differentiation by the AIDS retrovirus (HTLV-III/LAV) (0)
Live with Dr. Fauci (0)
8:30 am OPEN SESSION: Welcome and NIH Director's Report (0)
Fifth International Conference on AIDS : the Scientific and Social Challenge; symposium; role of macrophages and lymphocytes as reservoirs of HIV-1 (0)
Future directions in human immunobiology. (0)
1122 THE AMERICAN COLLEGE OF RHEUMATOLOGY 1990 CRITERIA FOR THE CLASSIFICATION OF GIANT CELL ARTERITIS (0)
IMMUNOFLUORESCENT STUDIES IN ADULT CELIAC DISEASE TABLE (0)
Information , Inspiration and Advocacy for People Living with HIV / AIDS (0)
Acquired immunodeficiency syndrome (AIDS). (0)
Correction (0)
Science for the common good. (0)
146 α4β7: A Newly Discovered Receptor for HIV (0)
395 The effect of elective C-section, preterm labor and chorioamnionitis on fetal lymphocyte activation and susceptibility to HIV infection (0)
Biographical Memoirs: Maurice R. Hilleman (0)
World AIDS Day 2003. (0)
Anthony Fauci (0)
THE HEMODYNAMIC EFFECTS AND SAFETY OF IV PENTAMIDINE (0)
of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides (0)
Infectious complications of cyclophosphamide treatment for vasculitis. (0)
Correction. (0)
Introduction:Advances in the immunology of human immunodeficiency virus (HIV) infection (0)
Chapter 19. Mechanisms of Action of Glucocorticosteroids (0)
Opening Keynote Session (0)
25 years of AIDS (0)
The George M. Kober lecture. Basic immunology: the path to the delineation of the immunopathogenic mechanisms of HIV infection. (0)
Chapter 8 – Establishment of Human—Human and Human—Mouse B Cell Hybrids and Their Use in the Study of B Cell Activation (0)
Faith, Science, and Trust: African American Clergy & Community Conversation on COVID-19 (0)
Response : Correlates of Protective Viruses Damaging to HIV Infection (0)
Protection of rhesus macaques against vaginal SHIV challenges by VRC01 and an anti-α4β7 antibody (0)
Introduction: Recent advances in the pathogenesis of human immunodeficiency virus infection (0)
Immunoregulation by Human Lymphocyte Subpopulations (0)
The revolution in the approach to allergic and immunologic diseases. (0)
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine (0)
E109 Ending the HIV/AIDS Pandemic: Research and Implementation (0)
The rapid spread of Zika virus through the Americas and its devastating consequences for pregnant women and infants have precip (0)
PRESENTATION OF THE C. EVERETT KOOP HIV/AIDS HEALTH LEADERSHIP AWARD TO VADM C. EVERETT KOOP, MD, SCD, 13TH U.S. SURGEON GENERAL (0)
Leukotriene C/sub 4/ (LTC/sub 4/) produced by a human T-T hybridoma suppresses pokeweed mitogen (PWM) induced immunoglobulin (Ig) production by human mononuclear cells (0)
Concise review: the polypill in cardiovascular disease prevention (0)
Harrison's Online Updates (0)
Correction (0)
syndrome. II. Clinical manifestations A clinicopathologic correlation of the idiopathic hypereosinophilic (0)
From the National Institutes of Health. (0)
Factors AssociatedWith AMR and Key Response Strategies (0)
Correction (0)
Immunologic Approaches to the Therapy of Auto-Immune Salivary Gland Disease (0)
Global Health and Infectious Diseases: A Look to the Future (0)
Acquired Immune Deficiency Syndrome (0)
Ending the Global HIV Epidemic Begins at the Individual National Level: An Update from the United States (0)
SHORT COMMUNICATION Relationship of the Genes for Chediak-Higashi Syndrome (Beige) and the T-Cell Receptor y Chain in Mouse and Man (0)
Contributors (0)
In memoriam: Albert Z. Kapikian, MD, 1930-2014. (0)
Factitious Fever and Self-Induced Infection (0)
The following protocols describe PCR amplification and polyacrylamide gel electrophoresis conditions for subtype determination of HIV-1 envelope (env) sequences using heteroduplex mobility assay (0)
Modulation of surface ia expression on human b lymphocytes (0)
Does Contrast Enhancement Predict Survival in Progressive Multifocal Leukoencephalopathy ? (0)
Challenges and similarities in HIV, COVID-19 crises: a Q&A with Anthony Fauci, MD. (0)
Acknowledgment to Dartmouth Medical Center (0)
The T4 epitope is not required for a normal replicative cycle of human immunodeficiency virus. (0)
LORENZO MORETTA , ANt ) (0)
Cell-mediated immunity-resistance to infection and so much more. (0)
Macrophage-Tropic HIV Envelope T Cells by + Primary Human CD 4 Receptor 5 and Focal Adhesion Kinase in Intracellular Association of CC Chemokine Induction of Phosphorylation and (0)
Author index (0)
Contents, Vol. 51, 1976 (0)
The U.S. Presidential Election (0)
Alteration of T lymphocyte subpopulations and presence of suppressor monocytes in tuberculosis (TB): The effects of anti-TB therapy (0)
C. EVERETT KOOP, 14 OCTOBER 1916 - 25 FEBRUARY 2013. (0)
IN VITRO REACTIVATION OF HIV-1 FROM LATENTLY INFECTED, RESTING CD4+ T CELLS BY HTLV-I-INFECTED CELL-DERIVED SOLUBLE FACTORS. (0)
Comparison of the relative cytotoxic effector cell capabilities and the proportions of cells bearing various surface markers in human tonsil and peripheral blood mononuclear cells. (0)
Introduction to the Proceedings of the 4th World Congress on Tuberculosis (0)
Acquired Immune Deficiency Syndrome (AIDS): Basic findings (0)
Correction (0)
The Ebola Epidemic of 2014–2015 (0)
Human B-Cell Growth and Differentiation Factors Secreted by T-Cell Hybridomas (0)
Acute Renal Failure (0)
Cytotoxic Effector Cells in the Bone Marrow of Normal Humans (0)
Correction (0)
Immunologic Approaches to the Therapy of Autoimmune Salivary Gland Disease (0)
Vitamin and Trace Mineral Deficiency and Excess (Chapter 326) (0)
Letter from Anthony Fauci to Joshua Lederberg (0)
Correction (0)
Immunology of the acquired immunodeficiency syndrome. (0)
The acquired immunodeficiency syndrome (AIDS): an update. (0)
Fifty years: advancing knowledge, improving health. (0)
Cytotoxic effector capacity of bone marrow mononuclear cells. (0)
Etiology of the acquired immunodeficiency syndrome (0)
Correction (0)
Correlates of Protective Viruses Damaging to HIV Infection (0)
and B Cell Helper Function (0)
Determination of Neutrophil Half-Life (0)
Letter from Anthony Fauci to C. Everett Koop (0)
Interleukin 2 in vitro corrects the defect in natural killer cell activity in the chediak higashi syndrome (0)
Immuno-incompetent Patients* (0)
Detection Assays for HIV Proteins (0)
Comments on “ Cytomegalovirus ( CMV ) – Encoded UL 144 ( Truncated Tumor Necrosis Factor Receptor ) and Outcome of Congenital CMV Infection ” (0)
Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states. (0)
News in brief (0)
News in brief (0)
Development of Effective Vaccines Commentary against Pandemic Influenza (0)
Michael M. Frank: February 28, 1937–August 1, 2019 (0)
Facial Erysipelas in the Immunocompromised Host (0)
The Human B Cell Cycle: Activation, Proliferation, and Differentiation (0)
SUMMARY OF WORKSHOP: HUMAN B CELL FUNCTION: RECENT ADVANCES, UNANSWERED QUESTIONS, AND FUTURE DIRECTIONS (0)
Harrison's Infectious Diseases; Second Edition. (0)
Emerging Infectious Diseases—Reply (0)
Cytokines and cytokine antagonists control the replication of the human immunodeficiency virus (HIV) in vitro (0)
PLAQUE FORMING CELL ASSAY FOR THE MEASUREMENT OF POLYCLONAL ACTIVATION OF HUMAN PERIPHERAL BLOOD LYMPHOCYTES. CELLULAR REQUIREMENTS AND INTERACTIONS (0)
THE ROLE OF SEQUENTIAL GALLIUM SCANNING IN AIDS PATIENTS DURING TREATMENT FOR PNEUMOCYSTIS CARINII PNEUMONIA (0)
news in brief (0)
Lithium carbonate for recurrent fever and neutropenia (0)
Correction (0)
Correction (0)
Current therapy in allergy, immunology, and rheumatology, 1985-1986 (0)
Book ReviewTextbook of Immunology (0)
United States of America (0)
Harrison perensiple of internal widicin (0)
Book reviews (0)
Effect of hydrocortisone (OHC) on the recirculating lymphocyte pool in man (0)
Mechanisms of corticosteroid suppression of cytotoxic responses to alloantigens. (0)
Chronic, Recurrent Small-Vessel Cutaneous Vasculitis-Reply (0)
Clinical characteristics and outcomes of South-East Asian patients with Takotsubo ( stress-induced ) cardiomyopathy (0)
Harrison's Online Updates (0)
The Ohio State University Commencement Address by Anthony S. Fauci, Spring 2016 (0)
GENERAL DISCUSSION: CLINICAL IMPLICATIONS IN THE STUDY OF IN VITRO B CELL FUNCTION. II. (0)
A universal flu vaccine is vital: A century after the deadly pandemic of 1918, we're still not safe (0)
Efficient inhibition of HIV entry-1 virus by a new fusion protein with cd4 (0)
Japan to allow limited human embryonic cloning (0)
Preface Harrison's Manual of Medicine (0)
Correction (0)
The explosive pandemic of Zika virus infection occurring throughout South America (0)
Live chat with Dr. Fauci discussing how to slow the spread of Covid (0)
Correction (0)
Response : HIV Quasispecies and Resampling (0)
Protection against repeated vaginal SHIV challenges by a combination of VRC01 and an anti-α4β7 antibody (0)
Exogenous IL-2 Independent Antigen-Specific Human T Cells: Antigen-Specific Induction of Polyclonal B Cell Factors (0)
Identification, purification, and characterization of antigen-activated and antigen-specific human B lymphocytes (0)
Reply to Fedson (0)
8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada (0)
The Effects of Interleukin 2, Gamma Interferon, and B Cell Differentiation Factor on the Differentiation of Human B Cells (0)
Fever of Unknown Origin-Reply (0)
Correction (0)
C. Everett Koop (0)
Live with Dr. Anthony Fauci (0)
Harrison's 14 (0)
Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. (0)
Blocking α4β7 integrin delays viral rebound in SHIVSF162P3-infected macaques treated with anti-HIV broadly neutralizing antibodies (0)
Behavior Increased implementation of education programs and attempts to modify behavior Use of condoms and other barrier methods Treatment and prevention of drug and alcohol abuse Clean syringes (0)
The challenges of an HIV vaccine enterprise - Response (0)
Researchers Identify New Strain of HIV Derived from Gorillas (0)
The Challenge of Pandemic Preparedness (0)
Correction (0)
Correction (0)
Orbital Manifestations of Wegenerʼs Granulomatosis on Computer Assisted Tomography (0)
Correction (0)
Harrison's Online Updates (0)
What Will It Take to Respond to the Threat of Zika? (0)
25 years of AIDS. Interview by Simon Noble. (0)
A renaissance for HIV vaccines? (0)
PRELIMINARY RESULTS OF TRIMETREXATE (TMTX) ALONE OR IN COMBINATION WITH A SULFONAMIDE FOR THE TREATMENT OF PNEUMOCYSTIS PNEUMONIA IN AIDS PATIENTS (0)
Constitutive production of a reverse transcriptase negative aids retrovirus particle (0)
Correction (0)
Laudatio: in celebration of the 80th birthday of Maurice R. Hilleman, Ph.D. (0)
A Centenary Tale of Two Pandemics: The 1918 Inﬂuenza Pandemic and COVID-19, Part II. (0)
Etiology and immunopathogenesis of the acquired immunodeficiency syndrome (0)
Correction (0)
Letter from Anthony Fauci, National Institutes of Health to Harold Varmus (0)
Comprar Harrison’s Neurology in Clinical Medicine | Eugene Braunwald | 9780071741033 | Mcgraw-Hill Education (0)
Leading Edge Perspective EmergingPandemicDiseases : HowWeGottoCOVID-19 (0)
US and Cuban Scientists Forge Collaboration on Arbovirus Research. (0)
Connecting the dots on interferon responsiveness in HCV/HIV co-infection: The virus, the cytokine, the receptor and the gene (0)
Relationship between expression of Fc gamma receptors or Ia antigens and cytolytic activities of alloactivated human T cells. (0)
EARLY TREATMENT OF HIV-1 INFECTION. AUTHOR'S REPLY (0)
Prednisone dose in alternate day therapy (0)
E-102 Ending the HIV/AIDS pandemic: The convergence of treatment and prevention (0)
In Memoriam: Edwin D. Kilbourne, MD, 1920–2011 (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (0)
Comprar Harrison Manual de Medicina 19ª Ed. | D. Kasper | 9786071514097 | MCGRAW HILL (0)
LIB: State-of-the-Art, from Equipment to Researchers (0)
The Haskins Lectureship in Science Policy, November 15, 2002 (0)
Volume Information (0)
Thirty Years of HIV/AIDS: A Personal Journey (0)
Nurses play critical role in care of AIDS patients. (0)
An interview with Anthony S. Fauci, MD. Interview by Mark Mascolini. (0)
Special Plenary Session (0)
FOCUS Nov-06 Evidence-Based Conundrum (0)
ACTIVATION OF HUMAN B LYMPHOCYTES I. Direct P laque-Forming Cell Assay for the Measu remen t of Polyclonal Activation and Antigenic S t imula t ion of H u m a n B Lymphocytes (0)
Point man. Interview by Jeff Berry. (0)
Correction (0)
The Effects of the AIDS Epidemic on the Safety of the Nation ' s Blood Supply (0)
Emerging infectious diseases. Authors'reply (0)
Comprar Harrison's Gastroenterology And Hepatology 3rd Ed. | A. Fauci | 9781259835841 | MCGRAW HILL (0)
Harrison Manual de Medicina Interna 18ed (0)
Interleukin 2 in H U M a N B Cell Function (0)
PULSE CYCLOPHOSPHAMIDE THERAPY FOR WEGENER'S GRANULOMATOSIS. AUTHOR'S REPLY (0)
NIH Summit on Anti-SARS-CoV-2 Antibodies for Treatment and Prevention of COVID-19—Lessons Learned and Remaining Questions (0)
Correction (0)
SEPARATION METHODS, SURFACE MARKERS AND CYTOTOXIC CAPABILITIES OF HUMAN EOSINOPHILS (0)
Screening for HIV infection in sexually transmitted disease clinics. (0)
Peering into the Infectious Future Of Emerging Infectious Diseases (0)
A conversation with Tony Fauci. Interviewed by Ushma S. Neill. (0)
[Gentamicin in the treatment of respiratory tract infections in infancy]. (0)
In the News (0)
Cytomegalovirus-specific Cytotoxic Activities of Lymphocytes from Patients with the Acquired Immune Deficiency Syndrome (0)
Correction (0)
Multifactorial Nature ofHumanImmunodeficiency Virus Disease: Implications forTherapy (0)
human interleukin-1 Leukemic B-cell precursors constitutively express functional receptors for (0)
The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID) (0)
Vaccination and the Lasker Awards: Enduring Legacies. (0)
Legionnaires ' Disease and Acinetobacter Bacteremia (0)
Balancing today's patients and tomorrow data. (0)
16. The regulatory effects of cyclic AMP on human B cell activation (0)
Response: Correlates of Protective Viruses Damaging to HIV Infection. (0)

This paper list is powered by the following services:

Other Resources About Anthony Fauci

en.wikipedia.org

What Schools Are Affiliated With Anthony Fauci?

Anthony Fauci is affiliated with the following schools:

Why Is Anthony Fauci Influential?

Anthony Fauci's Published Works

Published Papers

Other Resources About Anthony Fauci

What Schools Are Affiliated With Anthony Fauci?

Image Attributions